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A novel nanofiber scaffold was fabricated and characterized as a potential antimicrobial wound 
dressing. Half generation polyamidoamine (PAMAM) dendrimer G3.5 was covalently 
conjugated to gelatin. Gelatin alone or with gelatin-dendrimer conjugates was electrospun into 
nanofiber scaffolds. Gelatin is a derivative of natural collagen, and it is biocompatible, non-toxic 
and inexpensive, making it a desirable component in a wound dressing. Dendrimers are synthetic 
polymers comprising of a central core, internal branches and reactive surface groups. They 
provide a structurally controlled architecture for drug release. Silver was incorporated into the 
scaffold in situ due to its broad spectrum of antimicrobial properties. The scaffolds were further 
crosslinked by photo curable PEG-diacrylate in solution or vapor to gain structure stability. The 
fabricated scaffolds with various compositions displayed a wide range of structure characteristics 
and properties in terms of fiber morphology, swelling and degradation, mechanical properties, 
antimicrobial activity and silver release kinetics. The scaffolds showed a similar fiber structure 
and morphology. It was found that the fiber diameter of the scaffolds containing silver was 
greater than scaffolds without silver. The porosity of the crosslinked scaffolds ranged from 
67.56% to 90.42% and also exhibited a high capacity of swelling and adsorption. The results of 
the antimicrobial assay showed that scaffolds containing silver could effectively inhibit growth 
of bacteria at the end of 48 h. In vitro silver release studies demonstrated that silver could be 




CHAPTER 1 INTRODUCTION 
Skin is the outermost layer of the body and therefore most easily susceptible to injuries or 
wounds. Wounds may result from a variety of sources like accidents, surgical procedures, burns, 
trauma, ulcers or diseases like diabetes. They need to be treated properly to ensure effective and 
rapid healing. Chronic wounds affect approximately 1.5 to 3 million Americans every year and 
account for $7 billion in healthcare worldwide (Margolis et al. 2002). Also, as the number of 
people suffering from diabetes is increasing, diabetic foot ulcers occur in almost 25% of the 
patients with diabetes (Centegra). 
A number of new materials that hold great promise towards wound treatment have been 
developed. Biocompatible materials like hydrogels, hydrocolloids, foams, scaffolds and gauze 
are being actively studied for developing effective wound dressing products. Recently, 
electrospun nanofiber scaffolds have become a subject of attention for development of composite 
wound dressings. Such electrospun scaffolds can be generated from natural and synthetic 
biopolymers. They mimic the extracellular matrix, are biocompatible, biodegradable with highly 
porous structures providing space for cell in growth and air and moisture exchange. Also, 
therapeutics such as drugs and growth factors can be incorporated into the scaffolds for enhanced 
treatment. 
The objective of this thesis was to synthesize and design a gelatin-dendrimer nanofiber scaffold 
with silver encapsulated as a potential antimicrobial wound dressing. Gelatin is a substance 
native to the human body. It is non-toxic, inexpensive and bio-compatible. Dendrimers are 
highly branched molecules comprising of a central core, internal branches and reactive surface 
groups. They provide a structurally stable architecture for drug delivery and controlled drug 
release. Silver is known for its antimicrobial properties and its use has been revived due to the 
emergence of antibiotic resistant organisms. 
The experimental protocol involved the preparation of gelatin-dendrimer conjugates and 
preparation of solutions for electrospinning scaffolds. Eight different solutions were prepared for 
electrospinning consisting of gelatin and gelatin-dendrimer with different concentrations of 
silver, 0.825 mg/ml, 1.65 mg/ml and 3.3 mg/ml. To improve their structural stability, the 
scaffolds were crosslinked by solution or vapor of PEG-diacrylate in the presence of 
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dimethoxyphenylacetophenone (photo-initiator) upon irradiation. The morphology, structure and 
fiber diameter of the scaffolds were examined by scanning electron microscopy (SEM). The 
crosslinked scaffolds were further characterized by determining the mechanical strength, 
porosity, permeability and swelling ratio. The antimicrobial activity of the scaffolds was 
investigated against two common wound pathogens: gram-positive Staphylococcus aureus and 
gram-negative Pseudomonas aeruginosa. Data were collected at 4 h, 24 h and 48 h time points. 
It was observed that the scaffolds with all concentrations of silver could inhibit the growth of 
bacteria efficiently at the end of 48 h. The in-vitro release kinetics of silver was studied by 

















CHAPTER 2 BACKGROUND 
2.1 Phases of wound healing 
A wound in the skin can be generated by physical or thermal damages or as a result of a medical 
condition (Boateng et al. 2008). Wounds may be classified as acute or chronic wounds. Acute 
wounds are injuries that heal within 8 to 12 weeks with minimum scar formation, whereas 
chronic wounds do not heal within 12 weeks (Boateng et al. 2008; Harding et al. 2002; Nicholas 
2002).  
Normal wound healing is a natural, biological process that leads to the growth and regeneration 
of tissue (Boateng et al. 2008). It involves platelets, neutrophils, macrophages, lymphocytes, 
fibroblasts, epithelial cells, growth factors and etc (Epstein et al. 1999). The normal process of 
wound healing consists of four phases namely: (i) Hemostasis, (ii) Inflammatory phase, (iii) 
Proliferative phase, and (iv) Maturation or remodeling phase (Ratner 2004).  A schematic 
diagram of the process is shown in Figure 1 and the phases are described as: 
2.1.1 Hemostasis 
The immediate reaction of our body, to a cut or injury to the skin, is bleeding from the injured 
blood vessels (Boateng et al. 2008). Bleeding activates the platelets and clotting factors that play 
an important role in hemostasis. The clotting cascade is activated and fibrinogen and thrombin 
form a stable fibrin clot to prevent further bleeding. Further, the clot protects the underlying 
injured tissue (Martin 1997; Ratner 2004).  Platelets secrete certain cytokines and growth factors 
such as platelet derived growth factor (PDGF) and transforming growth factor- β (TGF- β) to 
help in the healing process (Epstein et al. 1999). 
2.1.2 Inflammatory phase 
The inflammatory phase is characterized by swelling and redness at the area of injury. 
Neutrophils, lymphocytes and macrophages play an important role in inflammation by 
phagocytizing the bacteria and micro-organisms (Keast and Orsted). The release of plasma 
proteins at the wound site also causes vasodilation of the blood vessels (Boateng et al. 2008). 
Macrophages produce chemotactic and growth factors like interleukin-1 (IL-1), platelet derived 
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growth factor, transforming growth factor- β (TGF- β), epidermal growth factor, fibroblast 
growth factor and insulin-like growth factor which promote the proliferative phase of wound 
healing (Faler et al. 2006; Keast and Orsted). 
2.1.3 Proliferative phase 
The proliferative phase begins when fibroblasts enter the wound site and involves extracellular 
matrix (ECM) deposition, angiogenesis and epithelialization (Faler et al. 2006). Fibroblasts 
secrete collagen which is helpful for cell migration and proliferation (Faler et al. 2006). 
Epithelialization occurs with formation of new blood vessels. 
2.1.4 Maturation or remodeling phase 
This is the last phase of the healing process and may take from about several months to years to 
complete depending on wound type (Boateng et al. 2008). Fibroblasts facilitate the formation of 
a collagen network and remodeling to strengthen the scar. 
Figure 1: Phases of wound healing (Re-drawn from (Percival and Keith 2010)) 
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2.2 Factors affecting wound healing 
There are various factors that can result in an impaired wound healing (Guo and DiPietro 2010) 
and generally lead to a pathological wound (Boateng et al. 2008). Such factors can be classified 
as local and systemic factors (Guo and DiPietro 2010). Local factors are those that directly affect 
the wound (Guo and DiPietro 2010) such as infection, ischemia, oxygenation, topical agents, or 
foreign bodies (Guo and DiPietro 2010; Kerstein 1997; Waldorf and Fewkes 1995), whereas 
systemic factors are related to the health state of an individual, such as age, nutrition, diseases 
(diabetes, fibrosis, jaundice etc.), medications, smoking, or immunocompromised disorders 
(cancer, radiotherapy) (Guo and DiPietro 2010). Bacteria like Pseudomonas aeruginosa, 
Staphylococcus aureus, Streptococcus pyrogenes and Proteus, Clostridium and Coliform species 
are common wound pathogens and unfavourable (Boateng et al. 2008; Guo and DiPietro 2010). 
Studies have shown that skin graft healing was affected by P. aeruginosa and S. aureus and the 
presence of S. aureus was found in 94% of the ulcers (Gilliland et al. 1988). Production of excess 
collagen results in the formation of keloid scars (Martin 1997). Age also affects the healing 
process since aging decreases the ability to combat infection (Boateng et al. 2008). Also, poor 
nutrition such as vitamin, mineral and protein deficiency impair and delay the wound healing 
process (Hemila and Douglas 1999; Patel 2005; Rojas and Phillips 1999). Diseases like diabetes 
affect wound healing due to poor blood circulation and also they may delay inflammation and 
production of collagen (Boateng et al. 2008).  
2.3 Drugs, growth factors and other therapeutics to enhance the efficacy of the dressing 
Apart from developing dressings to protect wounds, research is being conducted to incorporate 
therapeutics into wound dressings. These incorporated agents play an active part in the wound 
repair process. For example, antimicrobial agents can be included to inhibit growth of micro-
organisms (Boateng et al. 2008).  
As antimicrobial agents are able to inhibit growth of micro-organisms and prevent infection in 
the wound area, they are mainly for diabetic foot ulcers (Nelson et al. 2006; O'Meara et al. 
2000), or wounds resulting from surgery or accidents (Harihara et al. 2006), where the risk of 
infection is high (Boateng et al. 2008). Commonly used antimicrobial agents are povidone-iodine 
with fabric dressings, silver with synthetic dressings, gentamycin with collagen dressings and 
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ofloxacin with silicone gel sheets (Boateng et al. 2008). The delivery of antibiotics to the wound 
site through wound dressings is preferred over systemic administration since the dosage required 
for the latter may lead to toxic reactions in the body or may be ineffective due to poor blood 
circulation to the extremities (Boateng et al. 2008) (e.g., diabetic foot ulcers). In addition, 
delivery of antibiotics through wound dressings decreases the occurrence of bacterial resistance 
and interference with the wound repair process (Doillon and Silver 1986).  
Growth factors play an active role in cell division, migration, differentiation and proliferation 
(Boateng et al. 2008). They can be incorporated into wound dressing to enhance the healing 
process by (i) increasing the activity of inflammatory cells and fibroblasts at the wound site and 
(ii) stimulating cellular proliferation and angiogenesis, which, in turn, affects the production and 
degradation of the extracellular matrix (Greenhalgh 1996; Komarcevic 2000). Various growth 
factors that have been identified to play a role in wound healing are epidermal growth factor 
(EGF), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), transforming 
growth factor-β (TGF- β) and insulin like growth factor (IGF-1) (Greenhalgh 1996; Steenfos 
1994). Different dressings have been investigated for delivering specific growth factors. 
Collagen dressings have been shown to effectively deliver EGF (Grzybowski et al. 1999) and 
PDGF (Koempel et al. 1998) and hydrogel dressings have been shown to deliver TGF-β 
(Puolakkainen et al. 1995). Research done by Park et al. (Park et al. 2004) showed that wound 
healing was more effective when a collagen dressing containing antibiotics and FGF was used as 
compared to collagen dressing with antibiotic only. 
2.4 Wound dressings 
An ideal wound dressing is one that promotes wound healing and provides optimal environment 
for wound healing to take place (Shanmugasundaram et al. 2006). The desired characteristics of 
a wound dressing are (Ngan 2005): 
 Maintaining optimum temperature and environment for wound healing 
 Protecting the wound from any injury and infection by bacteria or other micro-organisms 
 Controlling the moisture content 
 Providing mechanical support to the wound site 
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 Absorbing wound exudates and keeping wound area clean 
 Sterility and non-toxicity 
Wound dressings can be classified based on the type of material, function and physical form of 
the dressing (Boateng et al. 2008): 
Table 1: Classification of wound dressings (Boateng et al. 2008; Ngan 2005; Paul and Sharma 
2004) 
Type of Dressing Characteristics Example(s) 
Passive Products Comprise of traditional dressings Gauze and tulle dressings 
Interactive Products These are dressings composed from 
polymers which allow moisture and oxygen 
exchange but can keep bacteria out. These 
are mostly applied to wounds that produce 
low exudates 
Hydrogels and foam dressings 
Bioactive Products These comprise of dressings which deliver 
substances that can enhance the wound 
healing process 
Alginates, chitosan, collagens 
and hydrocolloids 
 
2.4.1 Traditional and modern dressings 
Wound dressings have evolved over the period of time from raw applications like medicinal 
plants/herbs, honey and etc., to commercially designed dressings (Boateng et al. 2008). Although 
medicinal herbs and plants have been shown to demonstrate antimicrobial activity and reduce 
inflammation, their direct application may be harmful as they could contain micro-organisms 
which would be a source of infection (Boateng et al. 2008). Therefore, it is important to maintain 
an aseptic environment for wound healing to take place and use sterile wound dressings (Boateng 
et al. 2008). The research done by Winter in the 1960s led to the development of an approach to 
maintaining a moist environment for enhanced wound repair (Winter 1962). This boosted the 
development of advanced dressings with added functionalities to enhance wound healing (Sai 
and Babu 2000).  
Traditional dressings consist of gauze, bandages or materials woven from fabric (Boateng et al. 
2008; Sai and Babu 2000). They are dry dressings and hence moisture content can easily 
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evaporate through them, thus not providing a moist environment for healing. They cannot inhibit 
entry of micro-organisms and also its adherence to the wound causes difficulty in removing the 
dressing. To overcome these drawbacks, tulle dressings, gauze meshes impregnated with 
paraffin, have been developed. They can be removed from skin with less pain (Boateng et al. 
2008; Sai and Babu 2000). However, traditional dressings need to be changed frequently and are 
less cost effective than synthetic/modern dressings (Harding et al. 2000). Due to these 
disadvantages, modern or synthetic dressings are being actively researched and developed for 
wound treatment. 
Synthetic or modern wound dressings are classified based on the starting material used. They 
include hydrocolloids, alginate, hydrogel, foam, biological dressings (Boateng et al. 2008). 
Hydrocolloid dressings are formed from colloidal (gel-like) substances added to adhesive 
compounds. They can be obtained in the form of thin films or sheets and are useful for treating 
light to moderately exuding wounds (Boateng et al. 2008). In the original state, hydrocolloid 
dressings are impermeable to water vapor. However, in the presence of wound exudates, the 
dressings change their structure to a gel-like covering hence becoming more permeable to water 
and oxygen (Thomas and Loveless 1997). They do not cause any pain upon removal and are 
particularly useful in pediatric wound care (Thomas 1992). Alginate dressings are composed of 
calcium alginate and are useful in moderate to heavily exuding wounds like bleeding (Boateng et 
al. 2008; Paul and Sharma 2004). They can be used in the form of fibers or foams (Boateng et al. 
2008). Similar to hydrocolloids, alginate dressings also can form a gel upon contact with the 
wound exudates. Upon application, ion exchange takes place between the exudates and alginate 
fibers to help form a protective gel (Thomas 2000). This helps control the moisture content and 
minimizes the pain during removal of the dressing (1994; Boateng et al. 2008; Gilchrist and 
Martin 1983).  
Hydrogels are hydrophilic substances composed of synthetic polymers and have high swelling 
capacity (Boateng et al. 2008; Sai and Babu 2000). They occur in the form of amorphous gel or 
as an elastic sheet. Hydrogel in the form of elastic sheet contains crosslinked polymers so that it 
can retain water (Boateng et al. 2008; Sai and Babu 2000).  They do not react with biological 
tissues, are permeable to water and metabolites (Wichterle and Lim 1960), provide a moist and 
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cool environment at the surface of the wound to reduce pain (Boateng et al. 2008; Sai and Babu 
2000) and promote reepithelization of wounds (Debra and Cheri 1998). Foam dressings are 
sheets composed of polymer solutions like polyurethane (Chardack et al. 1962), which provide a 
moist environment and thermal insulation at the wound site (Boateng et al. 2008). These 
dressings are highly porous in nature, can absorb large amounts of fluid and hence can be used 
for low, moderate or heavily exuding wounds (Thomas 1990). Biological dressings comprise 
dressings derived from natural tissues or tissue engineered products consisting of combination of 
polymers such as collagen, hyaluronic acid, chitosan and elastin (Bartlett 1981). The major 
characteristics that make them attractive components for wound healing, are biodegradability, 
biocompatibility, non-toxicity and an active role in promoting new tissue formation (Boateng et 
al. 2008; Kollenberg 1998; Ueno et al. 1999).  
2.4.2 Drug delivery for wound healing 
Drug delivery systems have been developed to increase the effectiveness of therapeutic drugs 
through controlled release. Local drug delivery can be achieved by encapsulating the drug into 
biopolymer matrices or by covalent attachment to dendrimer surface groups or other polymers 
(Saltzman and Olbricht 2002). Controlled delivery of antibiotics to the wound site is beneficial 
because it reduces the need to deliver high doses of antibiotics systemically (Boateng et al. 
2008). Dressings made from natural or synthetic biopolymers can be incorporated with drugs and 
growth factors for effective healing. Many polymeric dressings have been evaluated for 
controlled drug delivery including hydrogels based on poly(vinyl alcohol), poly(lactide-co-
glycolide), poly(vinyl pyrrolidone), poly(hydroxyl-alkylmethacrylates) and alginate, polymeric 
matrices prepared from hyaluronic acid, collagen or chitosan and synthetic dressings which 
include silicone gel sheets (Boateng et al. 2008). 
Controlled drug release at wounds is governed by swelling of the polymer matrix, diffusion of 
the drug, degradation of the scaffold or the combination of the above (Boateng et al. 2008; Sill 
and von Recum 2008). Diffusion of the drug and degradation of the scaffold are desirable but 
also disadvantageous because it may result in accumulation of the drug in large doses which can 





Dendrimers are a group of highly branched polymers suitable for numerous applications in 
nanomedicine and nanotechnology. Dendrimers were first developed by Tomalia et al (Tomalia 
et al. 1985). The term ‘dendrimer’ is derived from the Greek word ‘dendron’ meaning tree. They 
are globular in structure and comprise a central core, internal branches and many reactive surface 
groups. There are many properties of dendrimers that make them attractive for biomedical 
applications: (i) they are monodisperse macromolecules (consistent size and form); (ii) they have 
low polydispersity index; (iii) they are highly soluble and miscible due to their branched 
structure; (iv) drug molecules can be encapsulated in their central core or covalently attached to 
their surface groups; and (v) their structurally stable architecture permits controlled drug release 
(Klajnert and Bryszewska 2007). 
2.5.1 Synthesis of dendrimers 
Dendrimers can be synthesized by two major methods: divergent synthesis and convergent 
synthesis (Klajnert and Bryszewska 2007). In the divergent synthesis method (Figure 2), the 
dendrimer advances in the outward direction from a core molecule. The core molecule reacts 
with monomer molecules resulting in first generation of the dendrimer. Subsequent reactions 
with many monomers lead to the formation of successive generations of the dendrimer. The 
divergent method can be used for producing large quantities of dendrimers but faces difficulty in 
purifying the final product.  
Figure 2: Divergent method for synthesis of dendrimers 
 
In the convergent synthesis method (Figure 3), the dendrimer progresses inwards towards the 
core molecule. Two or more dendrons attached to the monomer molecules react with the core 
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molecule to form the dendrimer. The structure resulting from convergent synthesis has less 
defects and the final product is easier to purify. Due to steric hindrance, high generations of 
dendrimers are difficult to form by the convergent synthesis. 
Figure 3: Convergent method for synthesis of dendrimers 
 
2.5.2 Polyamidoamine (PAMAM) dendrimers 
PAMAM dendrimers can be synthesized by divergent synthesis to have an ethylenediamine 
(EDA) or an ammonia core with methyl acrylate and ethylene diamine branches (Klajnert and 
Bryszewska 2007; Tomalia et al. 1985). The reaction scheme for the synthesis is illustrated 
below (Klajnert and Bryszewska 2007):  
NH2CH2CH2NH2 + 4CH2CHCOOCH3 → NCH2CH2N (CH2CH2COOCH3) 4                       Step 1 
NCH2CH2N (CH2CH2COOCH3) 4 + 4NH2CH2CH2NH2 → 
NCH2CH2N (CH2CH2CONHCH2CH2NH2) 4 +4CH3OH                                                        Step 2  
Full generation (cationic) PAMAM dendrimers have terminal amine groups, whereas half 
generations (anionic) have terminal carboxyl groups as shown in Figure 4 and Figure 5, 
respectively (Klajnert and Bryszewska 2007). As the number of generations increase, the number 
of reactive surface groups is doubled (Klajnert and Bryszewska 2007).  
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Figure 4: Generation 2.0 PAMAM dendrimer 
 




2.6 Electrospun gelatin/dendrimer scaffold with silver 
Electrospinning is a popular technique used for the fabrication of nanoscale structures for various 
applications like wound dressings, drug delivery vehicles and tissue engineered scaffolds (Huang 
et al. 2004). The scaffolds produced from natural, biodegradable polymers have very small fiber 
diameter ranging from nano to micrometers which is suitable to replicate the structural 
morphology of the natural extracellular matrix of native tissues and organs (Huang et al. 2004).  
In this study, gelatin was the major component used since it is a natural biopolymer derived from 
collagen. It is biocompatible, biodegradable and can be commercially available at a relatively 
low cost (Zhang et al. 2005). It is popularly used in the field of medicine as a sealant for vascular 
prosthesis and as a wound dressing. However, gelatin is easily soluble in water and electrospun 
gelatin fibers can easily lose their structural stability in an aqueous medium. Hence, gelatin based 
scaffolds need to be crosslinked or incorporated with stabilizing polymers to retain its 
mechanical integrity as a tissue engineered construct (Zhang et al. 2005). Dendrimer can be 
covalently bound to gelatin and electrospun into a scaffold for drug encapsulation and drug 
delivery. 
Silver was selected as an antimicrobial agent due to its broad range of antimicrobial activity 
against gram-positive and gram-negative bacteria (Hromadka et al. 2008). It can also inhibit 
antibiotic resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA) and 
vancomycin-resistant enterococci (VRE) when used at proper concentrations (Warriner and 
Burrell 2005). Silver can kill micro-organisms by multiple mechanisms, it can change the 
structure and function of a bacterial cell by altering its protein structure or rupture the bacterial 
cell wall or block the respiratory pathway (Warriner and Burrell 2005). Silver based wound 
dressings and creams are used for wound healing and to maintain a microbe free environment at 
the wound site (Warriner and Burrell 2005). Silver based dressings are particularly used in burn 
wounds, chronic leg ulcers, diabetic wounds and traumatic injuries (Ip et al. 2006). There are 
various ways by which silver can be incorporated in the dressing such as silver nitrate, silver 
sulfadiazine, silver calcium phosphate or in the form of nanocrystalline silver (Warriner and 
Burrell 2005). The silver can be released from the dressing by means of diffusion to the surface 
of the wound (Agarwal et al. 2009).  
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Apart from the advantages of including silver in a dressing, there are certain difficulties faced 
with current topical silver dressings such as slow rate of release, staining at the wound area, rapid 
consumption of silver ions and patient comfort (Warriner and Burrell 2005). Due to these issues, 
silver based dressings need to be investigated and an optimum concentration of silver introduced 




















CHAPTER 3 EXPERIMENTAL MATERIALS AND METHODS 
3.1 Materials 
Table 2: List of materials 
Material Abbreviation 
Polyamidoamine (PAMAM) dendrimer generation 3.5, 10 wt% solution in 
methanol 
 




Ethyl ether (anhydrous) 
Ethanol (denatured) 











Phosphate buffered saline         



























Table 3: List of equipment 
Equipment name Purpose 
Rotary evaporator, LABOROTA 
4000 (Heidolph) 
To distill low boiling point chemicals from a mixture of compounds 
Flexi-dry MP controlled rate 
freezer (FTS Systems, Inc.) 
To freeze dry the sample 
Weighing scale  To measure the quantity of chemicals 
Long wave ultra-violet lamp, 
model B (UVP) 
For UV irradiation 
Ultra violet visible (UV-Vis) 
spectrophotometer (Genesys 6, 
Thermo electron Corporation) 
To measure the absorbance value or standard curve 
Electrospinner To electrospin scaffolds 
MTS Bionix 200 - Mechanical 
testing system 
To measure stress, strain and modulus 
Scanning electron microscope 
model  EVO 550 
To take images of the scaffold and measure the fiber diameter by 
Image Tool 
Autoclave To sterilize medium 
Incubator To control temperature and humidity of microbial culture 
Hood To maintain sterile conditions 
Eppendorf centrifuge model-
5415D 
To separate mixture of compounds based on density 
Varian vista MPX, ICP-OES To measure the concentration of metals in a sample by inductively 






3.3 Experimental methods 
3.3.1 Preparation of gelatin-dendrimer conjugates 
The protocol used for the preparation of gelatin-dendrimer conjugate was a slight modification to 
that used by Alicia Smith Freshwater (Smith-Freshwater 2009). Gelatin was conjugated with half 
generation PAMAM dendrimer G3.5. Briefly, 120 µl of G3.5 in methanol stock solution was 
dried by rotary evaporation and re-dissolved in 2 ml of distilled water. This solution was 
vortexed thoroughly and mixed with 3 mg of NHS and 5 mg of EDC while stirring for 24 h to 
achieve surface activated G3.5 (i.e., G3.5-NHS). To prepare the gelatin solution, 20 mg of 
gelatin was added to 20 ml of 0.1N NaHCO3 solution and completely dissolved by stirring at 
80°C until it formed a clear solution. At 24 h, the gelatin solution was added to G3.5-NHS 
solution and kept in an ice bath for 4 h. It was then centrifuged for 20 min at 10 rpm and the 
supernatant was added drop wise to 50 ml of ethyl ether and refrigerated for 24 h. It was then 
centrifuged for 20 min at 10 rpm and the precipitate was collected. The precipitate was further 
purified by rapid dialysis using 12-14 kDa MWCO dialysis tubing. The purified solution was 
lyophilized by FTS to obtain gelatin-dendrimer conjugates. 
3.3.2 Preparation of sample solutions for electrospinning 
Eight different sample solutions were prepared using HFP as a solvent. The types of scaffolds 
electrospun and their constituents are summarized in Table 4. The reason for electrospinning 
eight different scaffolds with varying amounts of silver was to compare the characteristics of 
these scaffolds against each other and to determine the optimum silver composition against 
infection. The solutions were mixed thoroughly for 24 h on a shaker plate prior to 
electrospinning. 
3.3.3 Electrospinning 
A schematic diagram of the electrospinning technique is illustrated in Figure 6. In the 
electrospinning process, electrical charge is applied to draw fine fibers from the solution. The 
solution for electrospinning is loaded into a syringe and a positively charged electrode is attached 
to the needle of the syringe. The voltage applied results in an electric field and the drop of  
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Table 4: Solutions prepared for electrospinning scaffolds (The solutions were prepared in 10 ml 
of HFP) 
Scaffold Gelatin (mg/ml) Gelatin-dendrimer 
conjugate (mg/ml) 
Silver acetate (mg/ml) 
S1 100 0 0 
S2 100 0 3.3 
S3 100 0 1.65 
S4 100 0 0.825 
S5 96 4 0 
S6 96 4 3.3 
S7 96 4 1.65 
S8 96 4 0.825 
 
Figure 6: Schematic diagram of electrospinning (Re-drawn from (Sill and von Recum 2008)) 
 
polymer solution at the tip of the needle is altered into a conical shape known as the Taylor cone. 
As the strength of the electric field increases, the polymer solution jet is elongated to form long, 
thin fibers as a result of solvent evaporation. The fibers are collected on a collector or mandrel 




Particularly, the electrospinning solution was loaded into a 10 ml Becton Dickinson syringe and 
placed in a KD Scientific syringe pump for electrospinning. The syringe pump was set to deliver 
the solution at a rate of 5 ml/h. A voltage of 25 kV was applied to the needle of the syringe by a 
high voltage power supply (Spellman CZE1000R, Spellman High Voltage Electronics 
Corporation). The mandrel chosen for collecting the fibers was a flat, stainless steel mandrel 7.5 
cm x 2.5 cm x 0.5 cm (L x W x T). It was placed approximately 125 mm from the needle tip and 
rotated at ~500 rpm for uniform collection of the fibers. After electrospinning was completed, 
the scaffold was carefully removed from the mandrel, placed in a fume hood for degassing and 
stored in a moisture free environment. 
3.3.4 Crosslinking 
After electrospinning, the scaffolds were crosslinked to increase structure stability and 
mechanical properties. For each scaffold, 100 µl of PEG diacrylate, 4 mg of 
dimethoxyphenylacetophenone (photo-initiator) and 2 ml of ethanol were used to prepare the 
crosslinking solution. The solution was poured onto a scaffold of 7.5 cm x 5 cm and of varied 
thickness and allowed to stay for about 30 min. The scaffold was then held under UV light for 2 
min on each side. This method is referred to as the solution method. As an alternative method, 
vapors were used for crosslinking the scaffolds. The solution was heated in a water bath and the 
scaffold was crosslinked by the vapors. It was then held under UV light for 2 min on each side. 
This method is referred to as the vapor method. The scaffolds crosslinked by the vapor method 
did not retain their structure in aqueous medium and could be only characterized for 
morphology, fiber diameter, and tensile properties. Their data is shown in Appendix C. 
3.4 Characterization 
3.4.1 Ninhydrin assay 
Ninhydrin assay was performed to confirm the conjugation of dendrimer to gelatin. The 
ninhydrin stock solution was prepared by dissolving 30 mg of ninhydrin in 10 ml of ethanol. 
Five different concentrations of gelatin were prepared and mixed with 1 ml ninhydrin solution 
and a standard curve (Figure 7) was obtained using UV-Vis spectrophotometer. 1 mg of G3.5-
gelatin conjugate was mixed with 1 ml of DI water and 1 ml of ninhydrin solution. This mixture 
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was heated to approximately 80°C for 5-10 min and cooled to 20-25°C and the absorbance was 
measured at 570 nm. The absorbance value of G3.5-gelatin conjugate mixed with ninhydrin was 
compared to the standard curve of gelatin mixed with ninhydrin.  
Figure 7: Standard curve of gelatin (Ninhydrin assay) 


























Concentration of gelatin (mg/ml)
 
3.4.2 Scanning electron microscopy (SEM) 
SEM images of the scaffolds were taken to characterize the structure and morphology of the 
scaffolds. A small piece of sample from each scaffold was cut and gold sputter coated. Images 
were taken by Scanning Electron Microscope Model 550 at a magnification of 1200x. A scale 
bar of 10 µm is presented on each figure. Fiber diameter was calculated by using the UTHSCSA 




3.4.3 Tensile testing 
Tensile studies of the scaffold were performed to analyze the mechanical properties of the 
scaffolds. Tensile studies were done on the MTS Bionix 200®- Mechanical testing system with a 
100 N load cell. Six dog-bone shaped samples were cut out from each scaffold using a punch die. 
The thickness of the samples was measured in inches and the scaffolds were placed in the metal 
grips of the mechanical testing system moving at a rate of 10 mm/min. Stress, strain, modulus 
and energy to break were measured by the MTS Testworks software (version 4.04A).  
3.4.4 Porosity measurements 
Scaffold porosity was measured by taking out 1 cm x 1 cm samples from the scaffold and 
measuring the mass in g and thickness which ranged from 0.032 cm to 0.33 cm. Porosity was 
calculated by the formula: 
 
Where, Vg = Mass of scaffold/ Density of collagen (1.41 g/cm3) 
       Va = Apparent volume of the square section 1 cm x 1 cm x thickness 
Three samples (n=3) were used from each type of scaffold for the porosity measurements. 
3.4.5 Permeability and pore size measurements 
Permeability was measured by an apparatus designed by Scott Sell (Sell et al. 2008). 12 mm 
discs were punched out from the scaffolds and the time taken for 10 ml of water to pass through 
the disc was noted.  
Permeability was calculated as (Carr and Hardin 1987): 
 
Where,   τ = Permeability measured in Darcy 
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             Q=volume flowing through the system 
       T= scaffold thickness 
       µ= fluid viscosity (0.89 cP) 
       t = time taken for 10 ml water to flow through the scaffold (in seconds) 
       A= cross sectional area of scaffold (πr2) 
       P= applied pressure (ρgh) in atm 
      Where, ρ = density of water (1000 kg/m3) 
                  g = gravitational force (9.8 m/s2) 
                  h = total height of the system (m)  
The average pore size was calculated as (Carr and Hardin 1987): 
 
Three samples (n=3) were used from each type of scaffold for permeability measurements. 
3.4.6 Adsorption and swelling studies 
Simulated wound fluid (Parsons et al. 2005) (SWF) was used as the medium for swelling studies 
and antimicrobial activity to mimic the clinical conditions. SWF consists of 50% calf serum and 
50% maximum recovery diluent (0.1% w/v peptone and 0.9% w/v sodium chloride) (Parsons et 
al. 2005). 2.5cm x 2.5 cm of samples were cut out from each of the scaffolds and weighed (Wd). 
They were immersed in 5 ml of SWF at room temperature. The samples were taken out of the 
fluid, blot dried and weighed (Ws) at 10 min, 20 min, 30 min, 60 min, 90 min, 120 min, 24 h and 
48 h. The swelling ratio (%) was calculated by the formula (Parsons et al. 2005): 









3.4.7 In vitro degradation studies 
The in vitro degradability of the scaffolds without silver (S1 and S5) was evaluated. Four 
different media and conditions were used for the degradation studies: (i) incubation in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) at 37°C, (ii) DMEM supplemented with 10% FBS at room temperature, (iii) incubation in 
SWF at 37°C and (iv) incubation in cell conditioned medium at 37°C (Cell conditioned medium 
was DMEM supplemented with 10% FBS used for culturing confluent BJ-hTERT fibroblasts for 
24 h  in 96 x 16 mm sterile petri dish) . Nine samples from each scaffold of size 1 cm x 1 cm 
were weighed and immersed in 1.5 ml of each of the media mentioned above, for 24 h. After 6 h, 
12 h and 24 h three samples of each scaffold type were taken out from all media, centrifuged for 
20 min, frozen, then lyophilized and weighed. The average ratio of weight loss due to the 
degradation in each scaffold was calculated using the formula: 
 
Where, Wo = initial weight 
            Wd = weight of the sample after degradation 
3.4.8 Antimicrobial activity of silver 
The antimicrobial activity of silver was tested against common wound pathogens- gram positive 
Staphylococcus aureus (strain N315) and gram negative Pseudomonas aeruginosa (strain PA01). 
Colony plates of Staphylococcus aureus and Pseudomonas aeruginosa were cultured from the 
respective bacterial strains. 1 L of Luria agar was prepared containing 10 g of Tryptone, 5 g of 
yeast extract, 10 g of NaCl and agar to a final concentration of 1.5%. All the components were 
dissolved in 1 L of DI water. The medium was autoclaved at 121° C for 15 to 20 min and poured 
onto sterile petri plates and allowed to dry. Bacterial culture was inoculated using 1 colony in 3-4 
ml of SWF and incubated at 37° C overnight. 10 fold serial dilutions of the pure bacterial culture 
were made in SWF and 105 dilution repeats were prepared in test tubes. 2.5 cm x 2.5 cm sample 
taken out from each scaffold were inserted into the 105 dilution test tubes and incubated at 37° C. 
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One test tube containing no scaffold was used as control. 100 µl (0.1 ml) of aliquot was taken out 
from each of the test tubes at 4 h, 24 h and 48 h and plated on luria agar plates. The plates were 
incubated at 37° C in the incubator overnight and observed for any bacterial growth thereafter. 
After incubation, the number of colonies present was counted and colony forming units/ml 
(cfu/ml) was reported. 
3.4.9 Silver release studies 
The silver release from the scaffolds was studied in PBS. 2.5 cm x 2.5 cm of samples were taken 
out from the scaffolds, weighed and immersed into a capped glass vial containing 20 ml (0.02 L) 
of PBS. The glass vial was kept on a stir plate and the temperature was maintained at 37°C. At 
pre-determined time points: 1 h, 2 h, 3 h, 4 h, 24 h, 48 h, 72 h, 96 h, 120 h, 144 h, 168 h, 192 h, 
216 h, 240 h and 264 h, 10 ml (0.01 L) of PBS was transferred to a capped tube for silver content 
analysis. 10 ml of fresh PBS was added to the vial to maintain the volume of the medium for 
continuous observation. Silver content was analyzed by Inductively Coupled Plasma-Optical 
Emission Spectroscopy (ICP-OES/ ICP Varian Vista MPX).  ICP-OES is a technique used for 
analysis of trace metals present in a sample. The presence of the metals is detected by 
electromagnetic radiation emitted by excited atoms or ions, at a wavelength characteristic to a 
particular metal (Mermet 2005; Stefánsson et al. 2007). The concentration of the metal can be 
calculated by the intensity of the emission. 
Different concentrations of aqueous silver standards were prepared from a stock solution of 1000 
ppm (mg/L) silver standard. The intensity values of the known concentration of silver standards 
and the aliquots were recorded by ICP-OES. The calibration curve of silver (Figure 8) was used 
as a reference to calculate the concentration of silver in each of the aliquots. The concentration of 
silver in each aliquot ([concentration]to) was obtained in the units of parts per billion (ppb or 






Figure 8: Standard curve for silver 

















3.4.10 Statistical analysis 
Statistical analysis was performed on mean scaffold fiber diameters, tensile testing values, 
porosity, permeability, pore size, swelling ratio (%) and degradation. All statistical analysis was 
based on one way analysis of variance (ANOVA) and Tukey’s test for significance, performed 
on Minitab statistical software. A p-value less than 0.05 was considered statistically significant. 
Graphical representations of mean data were constructed with Microsoft Excel 2007 with error 









CHAPTER 4 RESULTS AND DISCUSSION 
4.1 Preparation and characterization of gelatin-dendrimer conjugates 
Coupling of G3.5 to gelatin was based on EDC/NHS chemistry and the reaction mechanism is 
shown in Figure 9. EDC along with NHS activated the terminal carboxyl groups of G3.5. The 
carboxyl groups and amine groups form an amide bond, hence coupling dendrimer to the gelatin 
backbone. 
Figure 9: Reaction mechanism- conjugation of dendrimer to gelatin 
 
The conjugation of gelatin and G3.5 was confirmed by the ninhydrin assay. Ninhydrin produces 
a chromophore when mixed with amine containing compounds and its presence can be detected 
by measuring the absorbance value by UV-Vis spectrophotometer at a wavelength of 570 nm.  
As shown in the standard curve of gelatin (Figure 7), 1 mg/ml of pure gelatin mixed with 1 ml of 
ninhydrin was found to have an absorbance value of 0.009 whereas 1 mg/ml of G3.5-gelatin 
mixed with 1 ml of ninhydrin solution gave an absorbance value of 0.002. The reduced 
absorbance was attributed to the decrease in the number of free amine groups and hence 




4.2 Morphology, fiber diameter and mechanical properties 
Electrospinning technique for fabrication of nanofiber scaffolds is gaining popularity due to its 
simplicity and ease of use (Kumbar et al. 2008). Electrospun scaffolds exhibit similarity in 
morphology to natural extra-cellular matrix (ECM), which is beneficial for tissue growth. 
Electrospinning can produce randomly oriented or aligned, continuous fibers which have high 
porosity and high surface area (Sill and von Recum 2008).  
Pure gelatin alone or with gelatin-dendrimer conjugates was electrospun to form nanofiber 
scaffolds. The scaffolds were further crosslinked to improve their structural stability. The data 
shown and discussed in this chapter are based on non-crosslinked scaffolds and scaffolds 
crosslinked by the solution method. The structure, morphology, mechanical properties and 
swelling ability of the scaffolds were evaluated. Different concentrations of silver acetate were 
incorporated in the scaffolds to determine the antimicrobial efficacy and silver release kinetics. 
SEM images of non-crosslinked scaffolds and scaffolds crosslinked by the solution method are 
shown in Figure 10 and Figure 11, respectively. It is observed that the scaffolds crosslinked by 
the solution method retained the nanofiber structure. There are many factors that affect the fiber 
diameter and morphology, such as concentration of polymer, viscosity, voltage applied, diameter 
of the needle and the rate at which the polymer solution is delivered (Lee et al. 2008). The fiber 
diameter of the non-crosslinked scaffolds ranged from 3.15 to 5.88 µm and that of the scaffolds 
crosslinked by the solution method ranged from 2.64 to 6.98 µm. A graphical representation of 
the data is shown in Figure 12. Also, statistical differences were analyzed using ANOVA in 
Minitab statistical software and the data is shown in Appendix A and Appendix B. It was 
observed that for both non-crosslinked and crosslinked scaffolds by the solution method, the 
fiber diameter of the gelatin-dendrimer scaffolds (S5, S6, S7, S8) was larger than that of the 
scaffolds containing gelatin only (S1, S2, S3, S4). Also it was observed that as the silver 
concentration in the gelatin scaffolds decreased, the fiber diameter decreased but for the gelatin-
dendrimer scaffolds as the silver concentration in the gelatin scaffolds increased. Half generation 
PAMAM dendrimers have a negative charge which could also have an influence on the electric 
field during electrospinning, thereby affecting the fiber diameter.  
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Figure 10: SEM images of the non-crosslinked scaffolds  (The white block arrows indicate the 
notation of the scale bar of 10 µm) 
 
       
       
       








Figure  11: SEM images of the scaffolds crosslinked by the solution method (The white 
block arrows indicate the notation of the scale bar of 10 µm) 
 
       
       
       




























Crosslinked by the solution 
method
 
Mechanical properties of a scaffold need to be evaluated for durability, stress resistance, 
flexibility and elasticity (Boateng et al. 2008). Peak stress, strain at break, energy to break and 
modulus of all scaffolds were determined by MTS Bionix and Testworks4 software. Tensile 
strength is the maximum stress a scaffold can withstand before breaking and determines the 
hardness of the scaffold. It also depends on the type and amount of polymer in the scaffold 
(Boateng et al. 2008). Strain at break describes the ductility and brittleness of the scaffold and 
also tells about the elongation of the scaffold at breaking point (Boateng et al. 2008). The 
mechanical properties and fiber diameter of the non-crosslinked and crosslinked scaffolds by the  
solution method are shown in Table 5 and Table 6, respectively; and a graphical representation 
of stress, strain and modulus data is shown in Figure 13. The mean stress of the non-crosslinked 
scaffolds ranged from 1.063 to 2.087 MPa (Appendix B) and that of crosslinked scaffolds by the 
solution method ranged from 0.692 to 3.125 MPa with a pooled standard deviation of 0.8616 
(Appendix A). Mean stress for crosslinked scaffolds by the solution method is statistically higher 
in the S1 scaffold type which contained only gelatin. It was observed that the stress values were 
higher for the non-crosslinked scaffolds as compared to the crosslinked ones except for scaffold 
S1. This behaviour was also observed in the modulus results. The scaffolds containing silver 
displayed higher stress values than scaffolds without silver. The mean strain for the non 
crosslinked scaffolds ranged from 0.015 to 0.040 mm/mm and for the crosslinked scaffolds by 
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the solution method ranged from 0.020 to 0.067 mm/mm. The strain values for crosslinked 
scaffolds were higher than the non-crosslinked scaffolds except for scaffold S2.  
Further characterization to determine the porosity, permeability, swelling ratio, antimicrobial 
activity and silver release kinetics was performed only on scaffolds crosslinked by the solution 
method since they could retain their stability in aqueous medium. 












S1 3.15 ± 0.72 1.136 ± 0.319 47.134 ± 6.463 0.028 ± 0.007 0.203 ± 0.097 
S2 4.85 ± 1.64 1.646 ± 1.016 93.636 ± 46.672 0.040 ± 0.038 0.272 ± 0.286 
S3 4.07 ± 1.15 1.922 ± 1.128 99.276 ± 45.636 0.022 ± 0.007 0.13 ± 0.050 
S4 3.95 ± 1.96 1.063 ± 0.323 64.841 ± 15.302 0.018 ± 0.007 0.107 ± 0.064 
S5 3.20 ± 0.90 1.399 ± 0.578 80.525 ± 20.326 0.022 ± 0.005 0.183 ± 0.090 
S6 4.12 ± 1.34 1.908 ± 0.519 66.580 ± 18.809 0.037 ± 0.009 0.476 ± 0.173 
S7 5.88 ± 1.88 2.087 ± 0.335 104.835 ± 18.741 0.027 ± 0.006 0.332 ± 0.174 
S8 5.59 ± 3.83 1.549 ± 0.363 100.319 ± 27.641 0.015 ± 0.005 0.137 ± 0.079 
 








Strain at break 
(mm/mm) 
Energy to break 
(N*mm) 
S1 2.64 ± 0.53 3.125 ± 1.443 80.835 ± 24.326 0.050 ± 0.009 0.060 ± 0.366 
S2 4.71 ± 1.90 1.485 ± 0.703 92.709 ± 35.127 0.020 ± 0.015 0.011 ± 0.075 
S3 4.24 ± 1.27 1.760 ± 0.774 58.330 ± 20.242 0.037 ± 0.008 0.306 ± 0.205 
S4 4.08 ± 1.02 0.692 ± 0.587 38.271 ± 12.854 0.033 ± 0.019 0.115 ± 0.140 
S5 4.85 ± 1.55 1.196 ± 1.246 53.443 ±  53.337 0.052 ± 0.012 0.278 ± 0.319 
S6 4.08 ± 1.80 1.581 ± 0.826 59.370 ± 27.612 0.063 ± 0.055 0.422 ± 0.203 
S7 6.7 ± 3.19 1.447 ± 0.250 33.804 ± 8.913 0.067 ± 0.009 0.646 ± 0.102 



































































Crosslinked by the solution method
 
4.3 Scaffold porosity, permeability, swelling and degradation studies 
The porosity, permeability and swelling ability of the scaffolds were evaluated to verify their 
capability for medium exchange. Porosity is the measure of void space within the scaffolds. The 
graphical data for porosity is shown in Figure 14 and the statistical analysis for the data is shown 
in Appendix A. The porosity of the scaffolds crosslinked by the solution method ranged from 
67.56 to 90.42% which is suitable as a tissue engineered scaffold for adequate moisture and 
oxygen exchange to underlying cells (Freed et al. 1994). The porosity of scaffold S8 was 
significantly higher than the porosity of scaffolds S3, S4 and S5 and highest among all the 
porosity values. Permeability is the measure of the ease of flow of fluid through the scaffold. 
Permeability ranged from 0.1673 to 2.428 Darcy and is depicted in Figure 15. Also the statistical 
analysis for permeability and pore size data is shown in Appendix A. It is observed that the 
gelatin-dendrimer scaffolds containing silver had lower permeability values as compared to the 
gelatin scaffolds containing silver but the statistical analysis shows that the data is not 
statistically significant. This lower permeability values of the gelatin-dendrimer scaffolds 
containing silver may be due to their higher fiber diameter. Pore size of the scaffolds show a 
similar trend to what was found in permeability as shown in Figure 16. 
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Adsorption and swelling studies were done to determine the swelling capacity of the scaffolds. 
Wounds that have extensive bleeding and heavy amounts of exudate require dressings to absorb 
quickly and maintain a clean environment at the wound site. The swelling studies were carried 
out in the SWF to replicate the clinical conditions. A graphical representation of the data is 
shown in Figure 17 and a statistical analysis of the swelling ratio values at 48 h is shown in 
Appendix A. All the scaffolds demonstrated a good swelling and absorbing capacity. The 
swelling ratio varied from 415 to 626 % at the end of 48 h (2880 min). It is observed that 
scaffold S4 had the highest swelling ratio.  































Gelatin is easily soluble and therefore scaffolds containing gelatin need to be evaluated for 
degradation. The scaffolds without silver (S1 and S5) were evaluated for degradation studies to 
observe the effect of temperature and other factors, if any, on the rate of degradation of the 
scaffold. It was observed that temperature did play a role in the rate of degradation as shown in 
Figure 18 for scaffold S1 and S5. A statistical analysis of the data is shown in Appendix A. For 
both the scaffolds, the weight loss (%) was significantly lower when tested at room temperature 
as compared to incubation at 37°C. The type of medium also affected the rate of degradation. 
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Both the scaffolds degraded completely at the end of 24 h in all media at 37°C, with the weight 
loss being highest during incubation in cell conditioned medium. It was also observed that S5 
which contained gelatin-dendrimer conjugate had lesser degradation than S1 which contained 
only gelatin when incubated in same media at 37°C. 




































































4.4 Antimicrobial assay 
 The scaffolds crosslinked by solution method were tested for antimicrobial efficacy against two 
common wound pathogens, gram positive Staphylococcus aureus and gram negative 
Pseudomonas aeruginosa. Gram positive bacteria do not contain any outer membrane but have a 
thick peptidoglycan layer and stain dark blue or violet by Gram’s staining. In contrast, gram 
negative bacteria contain an outer membrane but have a thin peptidoglycan layer and stain pink 
by Gram’s staining. The results for colony forming units/ml and the images of the petri plates are 
shown in Table 7, Table 8, Figure 19 and Figure 20. It is observed that the growth of both 
bacteria increased in a span of 48 h for the culture test tubes with no sample (control) and those 
containing scaffold samples without silver (S1 and S5). For Staphylococcus aureus, it was 
observed that at the end of 4 h, bacterial growth was completely inhibited  in the test tubes 
containing S2, S3, S5 and S6, but there was some growth in the test tubes containing S4 and S8. 
Overall it was observed that all the scaffold samples containing silver inhibited the growth of 
Staphylococcus aureus by the end of 48 h. For Pseudomonas aeruginosa, it was observed that all 
the scaffold samples containing silver inhibited the growth of bacteria by the end of 48 h. 
Table 7: Antimicrobial activity against Staphylococcus aureus 
Scaffold type 4 h 24 h 48 h 
Control (untreated) 10 x 107cfu/ml 24 x 107 cfu/ml Bacterial lawn 
S1 5.1 x 107 cfu/ml 6 x 107 cfu/ml Bacterial lawn 
S2 No colonies No colonies No colonies 
S3 No colonies No colonies No colonies 
S4 0.7 x 107 cfu/ml No colonies No colonies 
S5 6 x 107 cfu/ml Bacterial lawn Bacterial lawn 
S6 No colonies No colonies No colonies 
S7 No colonies No colonies No colonies 





Table 8: Antimicrobial activity against Pseudomonas aeruginosa 
Sample type 4 h 24 h 48 h 
Control (untreated) Bacterial lawn Bacterial lawn Bacterial lawn 
S1 Bacterial lawn Bacterial lawn Bacterial lawn 
S2 No colonies No colonies No colonies 
S3 No colonies No colonies No colonies 
S4 No colonies No colonies No colonies 
S5 Bacterial lawn Bacterial lawn Bacterial lawn 
S6 No colonies No colonies No colonies 
S7 No colonies No colonies No colonies 
S8 No colonies No colonies No colonies 
 
4.5 Silver release kinetics 
Silver release kinetics were measured by means of diffusion of silver into PBS medium and 
analyzing the silver content by ICP-OES. A graphical representation of cumulative release of 
silver (%) over time is shown in Figure 21. It is observed that all the scaffolds containing silver 
show a similar drug release pattern over a span of 264 h (short term). Silver release was slow and 
a very small amount of silver was released at the end of 264 h. It is also observed that larger 
amount of silver is released from gelatin-dendrimer scaffolds as compared to gelatin scaffolds 
containing equal amounts of silver (i.e. S2 and S6, S3 and S7, S4 and S8). This may be due to 
the larger fiber diameter of gelatin-dendrimer scaffolds. Fibers with larger diameter have a 
greater surface area for diffusion. Comparison of the antimicrobial assay and silver release 
kinetics revealed that even a low amount of silver released could inhibit any bacterial growth by 
48 h.  
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This work demonstrated that silver containing nanofiber dressings composed of gelatin with or 
without gelatin-dendrimer conjugates could be fabricated by electrospinning. The scaffolds were 
successfully crosslinked by photo-polymerization using liquid or vapor form of PEG diacrylate 
for structure stability improvement. The characteristics in terms of morphology, fiber diameter, 
mechanical properties, porosity, permeability and swelling capability could be modulated by 
changing the composition of the scaffold. According to antimicrobial assay, silver-containing 
scaffolds could inhibit bacterial growth by 48 h. Silver could be released in a controlled manner 






CHAPTER 6 SUMMARY AND FUTURE WORK 
 
Tissue engineered scaffolds have a wide range of applications as a wound dressing, for tissue 
regeneration and development and as a vehicle for drug delivery. They mimic the natural extra-
cellular matrix and facilitate cell growth and proliferation. We designed a novel gelatin-
dendrimer nanofiber scaffold as a potential wound dressing. The scaffolds were characterized to 
quantify their mechanical properties, gas and nutrient flow capability, swelling capacity and drug 
release kinetics. The scaffolds which showed the desirable properties of a wound dressing are 
summarized in Table 9.  
Table 9: Summary table 
Properties S1 S2 S3 S4 S5 S6 S7 S8 
Stress          
Strain         
Porosity         
Permeability         
Swelling          
Antimicrobial 
activity 
           
Drug release         
 
The scaffolds were required to be crosslinked to acquire the properties of a tissue engineered 
scaffold. The scaffolds have a unique structural configuration in which covalently bound 
dendrimer is evenly distributed along the dimension of the nanofiber. The addition of dendrimer 
provides multiple functional groups for attachment of drugs and their controlled release. The 
scaffolds S2, S6 and S8 were highly porous in nature and the higher fiber diameter provided 
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greater surface area for diffusion and drug release. The scaffolds S1, S2, S4, S6 and S8 also 
exhibited high capacity of swelling and adsorption. The scaffolds S1 and S5 were found to be 
easily degradable when incubated in cell conditioned medium at 37°C. This could be due to 
gelatin which is easily soluble and needs higher density of crosslinking for stability. The 
concentration of PEG-diacrylate could be increased to improve the crosslinking density hence 
controlling the rate of degradation. We incorporated silver into the scaffold to determine its 
antimicrobial efficacy; various other antimicrobial agents can be used for future studies. The 
scaffolds with silver could effectively inhibit growth of bacteria by 24 h. Also the concentration 
of silver can be further reduced to avoid any potential accumulated toxicity. As future work, 
studies could be done to evaluate the effect and clearance of silver in vivo to get a better insight. 
The scaffolds fabricated show promise as a bioactive dressing to treat wounds. They exhibit the 
properties necessary to maintain a moist environment to facilitate wound healing.  
The process of wound healing and wound closure involves growth factors like FGF, PDGF and 
TGF-β. As an extended study, growth factors like TGF-β could be incorporated into the scaffolds 
to increase the rate of healing and for release studies. TGF-β promotes the production of collagen 
framework thus helping in the proliferative phase of wound healing. Also the designed scaffold 
can be used to deliver other therapeutics for treating a variety of wounds, including chronic 
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Interpretation of the statistical analysis shown in Appendix A, B and C 
 
Analysis of Variance (ANOVA): 
 
 P < 0.05 indicates that the data is statistically significant 
 
Tukey’s Pairwise Comparisons: 
 
 Tukey’s pairwise comparison is performed to determine if two data values is statistically 
different from one another 
 If the confidence interval (lower to upper) between two data values does not include a 
zero, the difference between them is statistically significant 
 If the confidence interval (lower to upper) between two data values includes a zero, the 






















Appendix A (Data for the scaffolds crosslinked by the solution method) 
 
One-way ANOVA: Fiber diameter 
 
Source   DF       SS     MS      F      P 
Factor    7   432.43  61.78  15.29  0.000 
Error   232   937.12   4.04 
Total   239  1369.55 
 
S = 2.010   R-Sq = 31.57%   R-Sq(adj) = 29.51% 
 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level   N   Mean  StDev  -------+---------+---------+---------+-- 
S1     30  2.638  0.525  (----*---) 
S2     30  4.714  1.902                (---*----) 
S3     30  4.244  1.273            (----*----) 
S4     30  4.084  1.016           (----*----) 
S5     30  4.845  1.547                (----*----) 
S6     30  4.079  1.800           (----*----) 
S7     30  6.704  3.189                             (----*----) 
S8     30  6.983  3.157                               (----*---) 
                         -------+---------+---------+---------+-- 
                              3.0       4.5       6.0       7.5 
 
Pooled StDev = 2.010 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.75% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S2   0.486   2.075  3.664                   (----*----) 
S3   0.017   1.606  3.195                 (----*-----) 
S4  -0.143   1.446  3.035                 (----*----) 
S5   0.618   2.207  3.796                   (----*-----) 
S6  -0.148   1.441  3.030                 (----*----) 
S7   2.477   4.066  5.655                         (-----*----) 
S8   2.756   4.345  5.934                          (----*-----) 
                           -----+---------+---------+---------+---- 
                             -3.0       0.0       3.0       6.0 
 
 
S2 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S3  -2.058  -0.469  1.120          (----*-----) 
S4  -2.219  -0.630  0.959          (----*----) 
S5  -1.458   0.131  1.720            (----*-----) 
S6  -2.224  -0.635  0.954          (----*----) 
S7   0.401   1.990  3.579                  (-----*----) 
S8   0.681   2.270  3.859                   (-----*----) 
                           -----+---------+---------+---------+---- 
                             -3.0       0.0       3.0       6.0 
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S3 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S4  -1.749  -0.160  1.429           (----*-----) 
S5  -0.988   0.601  2.190              (----*----) 
S6  -1.754  -0.165  1.424           (----*-----) 
S7   0.871   2.460  4.049                    (----*----) 
S8   1.150   2.739  4.328                     (----*----) 
                           -----+---------+---------+---------+---- 
                             -3.0       0.0       3.0       6.0 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S5  -0.828   0.761  2.350              (-----*----) 
S6  -1.594  -0.005  1.584            (----*----) 
S7   1.031   2.620  4.209                    (-----*----) 
S8   1.310   2.899  4.488                     (-----*----) 
                           -----+---------+---------+---------+---- 
                             -3.0       0.0       3.0       6.0 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S6  -2.355  -0.766  0.823         (----*-----) 
S7   0.270   1.859  3.448                  (----*----) 
S8   0.549   2.138  3.727                   (----*----) 
                           -----+---------+---------+---------+---- 
                             -3.0       0.0       3.0       6.0 
 
 
S6 subtracted from: 
 
    Lower  Center  Upper  -----+---------+---------+---------+---- 
S7  1.036   2.625  4.214                    (-----*----) 
S8  1.315   2.904  4.493                     (-----*----) 
                          -----+---------+---------+---------+---- 
                            -3.0       0.0       3.0       6.0 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S8  -1.310   0.279  1.868             (----*----) 
                           -----+---------+---------+---------+---- 










One-way ANOVA: Stress  
 
Source  DF      SS     MS     F      P 
Factor   7  20.277  2.897  3.90  0.002 
Error   40  29.695  0.742 
Total   47  49.972 
 
S = 0.8616   R-Sq = 40.58%   R-Sq(adj) = 30.18% 
 
 
                          Individual 95% CIs For Mean Based on Pooled StDev 
Level  N    Mean   StDev    +---------+---------+---------+--------- 
S1     6  3.1250  1.4434                            (------*------) 
S2     6  1.4848  0.7033            (------*------) 
S3     6  1.7598  0.7738              (-------*------) 
S4     6  0.6922  0.5866    (------*------) 
S5     6  1.1965  1.2460         (------*------) 
S6     6  1.5805  0.8256             (------*------) 
S7     6  1.4473  0.2503           (------*-------) 
S8     6  1.5330  0.3484            (------*------) 
                            +---------+---------+---------+--------- 
                          0.0       1.0       2.0       3.0 
 
Pooled StDev = 0.8616 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
      Lower   Center    Upper     +---------+---------+---------+--------- 
S2  -3.2301  -1.6402  -0.0503         (-------*-------) 
S3  -2.9551  -1.3652   0.2247          (-------*-------) 
S4  -4.0227  -2.4328  -0.8429     (-------*-------) 
S5  -3.5184  -1.9285  -0.3386       (-------*-------) 
S6  -3.1344  -1.5445   0.0454         (-------*-------) 
S7  -3.2676  -1.6777  -0.0878         (-------*-------) 
S8  -3.1819  -1.5920  -0.0021         (-------*-------) 
                                  +---------+---------+---------+--------- 
                               -4.0      -2.0       0.0       2.0 
 
 
S2 subtracted from: 
 
      Lower   Center   Upper     +---------+---------+---------+--------- 
S3  -1.3149   0.2750  1.8649                  (-------*-------) 
S4  -2.3826  -0.7927  0.7972             (-------*-------) 
S5  -1.8782  -0.2883  1.3016                (-------*-------) 
S6  -1.4942   0.0957  1.6856                  (------*-------) 
S7  -1.6274  -0.0375  1.5524                 (-------*-------) 
S8  -1.5417   0.0482  1.6381                 (-------*-------) 
                                 +---------+---------+---------+--------- 







S3 subtracted from: 
 
      Lower   Center   Upper     +---------+---------+---------+--------- 
S4  -2.6576  -1.0677  0.5222            (-------*-------) 
S5  -2.1532  -0.5633  1.0266              (-------*-------) 
S6  -1.7692  -0.1793  1.4106                (-------*-------) 
S7  -1.9024  -0.3125  1.2774               (-------*-------) 
S8  -1.8167  -0.2268  1.3631                (-------*-------) 
                                 +---------+---------+---------+--------- 
                              -4.0      -2.0       0.0       2.0 
 
 
S4 subtracted from: 
 
      Lower  Center   Upper     +---------+---------+---------+--------- 
S5  -1.0856  0.5043  2.0942                    (-------*------) 
S6  -0.7016  0.8883  2.4782                     (-------*-------) 
S7  -0.8347  0.7552  2.3451                     (-------*-------) 
S8  -0.7491  0.8408  2.4307                     (-------*-------) 
                                +---------+---------+---------+--------- 
                             -4.0      -2.0       0.0       2.0 
 
 
S5 subtracted from: 
 
      Lower  Center   Upper     +---------+---------+---------+--------- 
S6  -1.2059  0.3840  1.9739                   (-------*-------) 
S7  -1.3391  0.2508  1.8407                  (-------*-------) 
S8  -1.2534  0.3365  1.9264                   (-------*-------) 
                                +---------+---------+---------+--------- 
                             -4.0      -2.0       0.0       2.0 
 
 
S6 subtracted from: 
 
      Lower   Center   Upper     +---------+---------+---------+--------- 
S7  -1.7231  -0.1332  1.4567                (-------*-------) 
S8  -1.6374  -0.0475  1.5424                 (-------*-------) 
                                 +---------+---------+---------+--------- 
                              -4.0      -2.0       0.0       2.0 
 
 
S7 subtracted from: 
 
      Lower  Center   Upper     +---------+---------+---------+--------- 
S8  -1.5042  0.0857  1.6756                 (-------*-------) 
                                +---------+---------+---------+--------- 









One-way ANOVA: Strain 
 
Source  DF        SS        MS     F      P 
Factor   7  0.012315  0.001759  3.53  0.005 
Error   40  0.019907  0.000498 
Total   47  0.032222 
 
S = 0.02231   R-Sq = 38.22%   R-Sq(adj) = 27.41% 
 
 
                            Individual 95% CIs For Mean Based on Pooled StDev 
Level  N     Mean    StDev  ---------+---------+---------+---------+ 
S1     6  0.04967  0.00937              (------*------) 
S2     6  0.01983  0.01508  (------*------) 
S3     6  0.03700  0.00780        (-------*------) 
S4     6  0.03267  0.01933       (------*------) 
S5     6  0.05167  0.01147              (-------*------) 
S6     6  0.06317  0.05478                   (------*-------) 
S7     6  0.06700  0.00897                    (-------*------) 
S8     6  0.02650  0.00432    (-------*------) 
                            ---------+---------+---------+---------+ 
                                   0.025     0.050     0.075     0.100 
 
Pooled StDev = 0.02231 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S2  -0.07100  -0.02983  0.01133      (-------*-------) 
S3  -0.05383  -0.01267  0.02850         (-------*--------) 
S4  -0.05817  -0.01700  0.02417        (--------*-------) 
S5  -0.03917   0.00200  0.04317            (-------*--------) 
S6  -0.02767   0.01350  0.05467              (--------*-------) 
S7  -0.02383   0.01733  0.05850               (-------*--------) 
S8  -0.06433  -0.02317  0.01800       (-------*--------) 
                                 --------+---------+---------+---------+- 
                                      -0.050     0.000     0.050     0.100 
 
 
S2 subtracted from: 
 
       Lower   Center    Upper  --------+---------+---------+---------+- 
S3  -0.02400  0.01717  0.05833               (-------*--------) 
S4  -0.02833  0.01283  0.05400              (--------*-------) 
S5  -0.00933  0.03183  0.07300                  (-------*--------) 
S6   0.00217  0.04333  0.08450                    (--------*-------) 
S7   0.00600  0.04717  0.08833                     (-------*--------) 
S8  -0.03450  0.00667  0.04783             (-------*--------) 
                                --------+---------+---------+---------+- 







S3 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S4  -0.04550  -0.00433  0.03683           (-------*-------) 
S5  -0.02650   0.01467  0.05583               (-------*-------) 
S6  -0.01500   0.02617  0.06733                 (-------*-------) 
S7  -0.01117   0.03000  0.07117                  (-------*-------) 
S8  -0.05167  -0.01050  0.03067          (-------*-------) 
                                 --------+---------+---------+---------+- 
                                      -0.050     0.000     0.050     0.100 
 
 
S4 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S5  -0.02217   0.01900  0.06017                (-------*-------) 
S6  -0.01067   0.03050  0.07167                  (-------*-------) 
S7  -0.00683   0.03433  0.07550                   (-------*-------) 
S8  -0.04733  -0.00617  0.03500           (-------*-------) 
                                 --------+---------+---------+---------+- 
                                      -0.050     0.000     0.050     0.100 
 
 
S5 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S6  -0.02967   0.01150  0.05267              (-------*--------) 
S7  -0.02583   0.01533  0.05650               (-------*-------) 
S8  -0.06633  -0.02517  0.01600       (-------*-------) 
                                 --------+---------+---------+---------+- 
                                      -0.050     0.000     0.050     0.100 
 
 
S6 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S7  -0.03733   0.00383  0.04500             (-------*-------) 
S8  -0.07783  -0.03667  0.00450    (--------*-------) 
                                 --------+---------+---------+---------+- 
                                      -0.050     0.000     0.050     0.100 
 
 
S7 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S8  -0.08167  -0.04050  0.00067    (-------*-------) 
                                 --------+---------+---------+---------+- 










One-way ANOVA: Modulus  
 
Source  DF     SS    MS     F      P 
Factor   7  16752  2393  2.83  0.017 
Error   40  33792   845 
Total   47  50544 
 
S = 29.07   R-Sq = 33.14%   R-Sq(adj) = 21.44% 
 
 
                        Individual 95% CIs For Mean Based on 
                        Pooled StDev 
Level  N   Mean  StDev  -------+---------+---------+---------+-- 
S1     6  80.84  24.33                  (-------*-------) 
S2     6  92.71  35.13                      (-------*-------) 
S3     6  58.33  20.24          (-------*-------) 
S4     6  38.27  12.85    (-------*-------) 
S5     6  53.44  55.34         (-------*-------) 
S6     6  59.37  27.61           (-------*-------) 
S7     6  33.80   8.91  (-------*-------) 
S8     6  69.39  21.30              (-------*-------) 
                        -------+---------+---------+---------+-- 
                              30        60        90       120 
 
Pooled StDev = 29.07 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
      Lower  Center  Upper  ---------+---------+---------+---------+ 
S2   -41.76   11.87  65.51              (--------*--------) 
S3   -76.14  -22.51  31.13        (--------*--------) 
S4   -96.20  -42.56  11.07     (--------*--------) 
S5   -81.03  -27.39  26.24       (--------*--------) 
S6   -75.10  -21.46  32.17        (--------*--------) 
S7  -100.66  -47.03   6.60    (--------*--------) 
S8   -65.07  -11.44  42.19          (--------*--------) 
                            ---------+---------+---------+---------+ 
                                   -60         0        60       120 
 
 
S2 subtracted from: 
 
      Lower  Center  Upper  ---------+---------+---------+---------+ 
S3   -88.01  -34.38  19.25      (--------*--------) 
S4  -108.07  -54.44  -0.80   (--------*--------) 
S5   -92.90  -39.27  14.37      (-------*--------) 
S6   -86.97  -33.34  20.30       (-------*--------) 
S7  -112.54  -58.91  -5.27  (--------*--------) 
S8   -76.95  -23.31  30.32        (--------*--------) 
                            ---------+---------+---------+---------+ 






S3 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S4  -73.69  -20.06  33.58         (--------*--------) 
S5  -58.52   -4.89  48.75           (--------*--------) 
S6  -52.59    1.04  54.67            (--------*--------) 
S7  -78.16  -24.53  29.11        (--------*--------) 
S8  -42.57   11.06  64.70              (--------*--------) 
                           ---------+---------+---------+---------+ 
                                  -60         0        60       120 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S5  -38.46   15.17  68.81               (--------*-------) 
S6  -32.54   21.10  74.73                (--------*-------) 
S7  -58.10   -4.47  49.17           (--------*--------) 
S8  -22.51   31.12  84.76                 (--------*--------) 
                           ---------+---------+---------+---------+ 
                                  -60         0        60       120 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S6  -47.71    5.93  59.56             (--------*--------) 
S7  -73.27  -19.64  33.99         (--------*--------) 
S8  -37.68   15.95  69.59               (--------*--------) 
                           ---------+---------+---------+---------+ 
                                  -60         0        60       120 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S7  -79.20  -25.57  28.07        (--------*--------) 
S8  -43.61   10.02  63.66              (--------*--------) 
                           ---------+---------+---------+---------+ 
                                  -60         0        60       120 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S8  -18.04   35.59  89.22                  (--------*--------) 
                           ---------+---------+---------+---------+ 














One-way ANOVA: Porosity  
 
Source  DF      SS     MS      F      P 
Factor   7  1402.2  200.3  14.02  0.000 
Error   16   228.5   14.3 
Total   23  1630.7 
 
S = 3.779   R-Sq = 85.99%   R-Sq(adj) = 79.85% 
 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level  N    Mean  StDev  -------+---------+---------+---------+-- 
S1     3  82.479  3.366                 (---*----) 
S2     3  85.981  1.593                    (----*----) 
S3     3  70.667  3.973     (----*---) 
S4     3  67.565  5.104  (----*---) 
S5     3  78.734  2.043             (----*---) 
S6     3  87.669  3.161                      (----*---) 
S7     3  84.832  1.758                   (----*---) 
S8     3  90.427  6.427                         (---*----) 
                         -------+---------+---------+---------+-- 
                               70        80        90       100 
 
Pooled StDev = 3.779 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.68% 
 
 
S1 subtracted from: 
 
      Lower   Center   Upper  -------+---------+---------+---------+-- 
S2   -7.190    3.501  14.193               (-----*----) 
S3  -22.505  -11.813  -1.121        (----*----) 
S4  -25.606  -14.914  -4.222      (-----*----) 
S5  -14.437   -3.745   6.947            (----*----) 
S6   -5.503    5.189  15.881                (-----*----) 
S7   -8.339    2.352  13.044               (----*-----) 
S8   -2.745    7.947  18.639                  (----*----) 
                              -------+---------+---------+---------+-- 
                                   -20         0        20        40 
 
 
S2 subtracted from: 
 
      Lower   Center   Upper  -------+---------+---------+---------+-- 
S3  -26.006  -15.314  -4.622      (----*-----) 
S4  -29.107  -18.416  -7.724    (-----*----) 
S5  -17.938   -7.247   3.445          (----*-----) 
S6   -9.004    1.688  12.380              (-----*----) 
S7  -11.841   -1.149   9.543             (----*-----) 
S8   -6.246    4.446  15.138                (----*-----) 
                              -------+---------+---------+---------+-- 






S3 subtracted from: 
 
      Lower  Center   Upper  -------+---------+---------+---------+-- 
S4  -13.793  -3.101   7.591            (----*-----) 
S5   -2.624   8.068  18.760                  (----*----) 
S6    6.310  17.002  27.694                      (-----*----) 
S7    3.473  14.165  24.857                     (----*----) 
S8    9.068  19.760  30.452                        (----*----) 
                             -------+---------+---------+---------+-- 
                                  -20         0        20        40 
 
 
S4 subtracted from: 
 
     Lower  Center   Upper  -------+---------+---------+---------+-- 
S5   0.477  11.169  21.861                   (-----*----) 
S6   9.411  20.103  30.795                        (----*----) 
S7   6.575  17.266  27.958                      (-----*----) 
S8  12.169  22.861  33.553                         (----*-----) 
                            -------+---------+---------+---------+-- 
                                 -20         0        20        40 
 
 
S5 subtracted from: 
 
     Lower  Center   Upper  -------+---------+---------+---------+-- 
S6  -1.758   8.934  19.626                  (----*-----) 
S7  -4.594   6.098  16.789                 (----*----) 
S8   1.001  11.692  22.384                    (----*----) 
                            -------+---------+---------+---------+-- 
                                 -20         0        20        40 
 
 
S6 subtracted from: 
 
      Lower  Center   Upper  -------+---------+---------+---------+-- 
S7  -13.529  -2.837   7.855            (-----*----) 
S8   -7.934   2.758  13.450               (----*-----) 
                             -------+---------+---------+---------+-- 
                                  -20         0        20        40 
 
 
S7 subtracted from: 
 
     Lower  Center   Upper  -------+---------+---------+---------+-- 
S8  -5.097   5.595  16.287                (-----*----) 
                            -------+---------+---------+---------+-- 















One-way ANOVA: Permeability  
 
Source  DF     SS    MS     F      P 
Factor   7  12.81  1.83  1.55  0.220 
Error   16  18.86  1.18 
Total   23  31.67 
 
S = 1.086   R-Sq = 40.46%   R-Sq(adj) = 14.41% 
 
 
                        Individual 95% CIs For Mean Based on 
                        Pooled StDev 
Level  N   Mean  StDev  --------+---------+---------+---------+- 
S1     3  1.713  1.421             (-------*--------) 
S2     3  1.690  1.343            (--------*--------) 
S3     3  2.079  0.636               (--------*--------) 
S4     3  1.564  1.115            (-------*--------) 
S5     3  2.428  1.229                 (--------*--------) 
S6     3  0.167  0.014  (--------*--------) 
S7     3  0.829  1.283       (--------*-------) 
S8     3  0.562  0.896     (--------*--------) 
                        --------+---------+---------+---------+- 
                              0.0       1.5       3.0       4.5 
 
Pooled StDev = 1.086 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.68% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S2  -3.095  -0.023  3.048          (---------*---------) 
S3  -2.705   0.366  3.437           (---------*---------) 
S4  -3.220  -0.149  2.922         (----------*---------) 
S5  -2.356   0.715  3.786            (---------*----------) 
S6  -4.617  -1.546  1.525     (---------*---------) 
S7  -3.955  -0.884  2.187       (---------*---------) 
S8  -4.222  -1.151  1.920      (---------*---------) 
                           --------+---------+---------+---------+- 
                                -3.0       0.0       3.0       6.0 
 
 
S2 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S3  -2.682   0.389  3.461           (---------*----------) 
S4  -3.197  -0.126  2.946         (----------*---------) 
S5  -2.333   0.738  3.810            (---------*----------) 
S6  -4.594  -1.523  1.549     (---------*---------) 
S7  -3.932  -0.861  2.211       (---------*---------) 
S8  -4.199  -1.128  1.944      (---------*---------) 
                           --------+---------+---------+---------+- 






S3 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S4  -3.586  -0.515  2.556        (---------*----------) 
S5  -2.722   0.349  3.420           (---------*---------) 
S6  -4.983  -1.912  1.159   (----------*---------) 
S7  -4.321  -1.250  1.821      (---------*---------) 
S8  -4.588  -1.517  1.554     (---------*---------) 
                           --------+---------+---------+---------+- 
                                -3.0       0.0       3.0       6.0 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S5  -2.207   0.864  3.935             (---------*---------) 
S6  -4.468  -1.397  1.674     (---------*----------) 
S7  -3.806  -0.735  2.336       (----------*---------) 
S8  -4.073  -1.002  2.069      (----------*---------) 
                           --------+---------+---------+---------+- 
                                -3.0       0.0       3.0       6.0 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S6  -5.332  -2.261  0.811  (---------*----------) 
S7  -4.670  -1.599  1.472    (----------*---------) 
S8  -4.937  -1.866  1.205    (---------*---------) 
                           --------+---------+---------+---------+- 
                                -3.0       0.0       3.0       6.0 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S7  -2.410   0.662  3.733            (---------*---------) 
S8  -2.677   0.395  3.466           (---------*----------) 
                           --------+---------+---------+---------+- 
                                -3.0       0.0       3.0       6.0 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  --------+---------+---------+---------+- 
S8  -3.338  -0.267  2.804         (---------*---------) 
                           --------+---------+---------+---------+- 















One-way ANOVA: Pore size 
 
Source  DF      SS      MS     F      P 
Factor   7  0.9393  0.1342  1.99  0.120 
Error   16  1.0787  0.0674 
Total   23  2.0180 
 
S = 0.2596   R-Sq = 46.55%   R-Sq(adj) = 23.16% 
 
 
                          Individual 95% CIs For Mean Based on 
                          Pooled StDev 
Level  N    Mean   StDev  ---+---------+---------+---------+------ 
S1     3  0.6106  0.3277             (--------*---------) 
S2     3  0.6299  0.2496              (--------*--------) 
S3     3  0.7286  0.1124                 (--------*--------) 
S4     3  0.5942  0.2810             (--------*--------) 
S5     3  0.7729  0.2207                  (--------*--------) 
S6     3  0.2082  0.0088  (--------*--------) 
S7     3  0.3583  0.3605      (--------*--------) 
S8     3  0.2821  0.3151    (--------*--------) 
                          ---+---------+---------+---------+------ 
                           0.00      0.35      0.70      1.05 
 
Pooled StDev = 0.2596 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.68% 
 
 
S1 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S2  -0.7152   0.0193  0.7539           (---------*----------) 
S3  -0.6165   0.1180  0.8526            (----------*---------) 
S4  -0.7509  -0.0164  0.7182          (----------*---------) 
S5  -0.5723   0.1623  0.8968             (---------*----------) 
S6  -1.1369  -0.4024  0.3322     (---------*----------) 
S7  -0.9868  -0.2523  0.4823       (---------*----------) 
S8  -1.0630  -0.3284  0.4061      (---------*----------) 
                              ---------+---------+---------+---------+ 
                                    -0.70      0.00      0.70      1.40 
 
 
S2 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S3  -0.6358   0.0987  0.8333            (---------*----------) 
S4  -0.7702  -0.0357  0.6989          (---------*----------) 
S5  -0.5916   0.1430  0.8775             (---------*----------) 
S6  -1.1562  -0.4217  0.3129    (----------*---------) 
S7  -1.0061  -0.2716  0.4630       (---------*----------) 
S8  -1.0823  -0.3478  0.3868      (---------*----------) 
                              ---------+---------+---------+---------+ 






S3 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S4  -0.8690  -0.1344  0.6001         (---------*----------) 
S5  -0.6903   0.0443  0.7788           (----------*---------) 
S6  -1.2550  -0.5204  0.2141   (----------*---------) 
S7  -1.1048  -0.3703  0.3643     (----------*---------) 
S8  -1.1810  -0.4465  0.2881    (----------*---------) 
                              ---------+---------+---------+---------+ 
                                    -0.70      0.00      0.70      1.40 
 
 
S4 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S5  -0.5559   0.1787  0.9132             (----------*---------) 
S6  -1.1205  -0.3860  0.3486     (---------*----------) 
S7  -0.9704  -0.2359  0.4987       (----------*---------) 
S8  -1.0466  -0.3121  0.4225      (----------*---------) 
                              ---------+---------+---------+---------+ 
                                    -0.70      0.00      0.70      1.40 
 
 
S5 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S6  -1.2992  -0.5647  0.1699  (----------*---------) 
S7  -1.1491  -0.4145  0.3200     (---------*----------) 
S8  -1.2253  -0.4907  0.2438   (----------*---------) 
                              ---------+---------+---------+---------+ 
                                    -0.70      0.00      0.70      1.40 
 
 
S6 subtracted from: 
 
      Lower  Center   Upper  ---------+---------+---------+---------+ 
S7  -0.5844  0.1501  0.8847             (---------*----------) 
S8  -0.6606  0.0739  0.8085            (---------*----------) 
                             ---------+---------+---------+---------+ 
                                   -0.70      0.00      0.70      1.40 
 
 
S7 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S8  -0.8107  -0.0762  0.6584         (----------*---------) 
                              ---------+---------+---------+---------+ 















One-way ANOVA: Swelling studies (data points at 48 h) 
 
Source  DF      SS     MS     F      P 
Factor   7  264049  37721  1.06  0.429 
Error   16  567362  35460 
Total   23  831410 
 
S = 188.3   R-Sq = 31.76%   R-Sq(adj) = 1.90% 
 
 
                        Individual 95% CIs For Mean Based on 
                        Pooled StDev 
Level  N   Mean  StDev   -+---------+---------+---------+-------- 
S1     3  595.4  144.9            (-----------*----------) 
S2     3  409.6   75.6   (----------*-----------) 
S3     3  650.1  233.7               (-----------*----------) 
S4     3  735.1  330.3                   (-----------*----------) 
S5     3  498.5  154.5       (-----------*----------) 
S6     3  717.0  168.1                  (-----------*----------) 
S7     3  527.3  188.1         (----------*-----------) 
S8     3  538.6   76.0         (-----------*----------) 
                         -+---------+---------+---------+-------- 
                        200       400       600       800 
 
Pooled StDev = 188.3 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.68% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S2  -718.5  -185.8  346.9     (---------*----------) 
S3  -478.1    54.7  587.4         (----------*----------) 
S4  -393.1   139.7  672.4           (----------*---------) 
S5  -629.6   -96.9  435.8      (----------*----------) 
S6  -411.1   121.6  654.4           (---------*----------) 
S7  -600.9   -68.1  464.6       (----------*---------) 
S8  -589.5   -56.8  476.0       (----------*----------) 
                           -------+---------+---------+---------+-- 
                               -500         0       500      1000 
 
 
S2 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S3  -292.2   240.5  773.2             (----------*---------) 
S4  -207.3   325.5  858.2               (----------*---------) 
S5  -443.8    88.9  621.7          (----------*---------) 
S6  -225.3   307.4  840.2              (----------*----------) 
S7  -415.1   117.7  650.4           (---------*----------) 
S8  -403.7   129.0  661.8           (----------*---------) 
                           -------+---------+---------+---------+-- 






S3 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S4  -447.7    85.0  617.7          (----------*---------) 
S5  -684.3  -151.6  381.2     (----------*----------) 
S6  -465.8    67.0  599.7          (---------*----------) 
S7  -655.5  -122.8  409.9      (----------*---------) 
S8  -644.2  -111.4  421.3      (----------*---------) 
                           -------+---------+---------+---------+-- 
                               -500         0       500      1000 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S5  -769.3  -236.5  296.2    (---------*----------) 
S6  -550.7   -18.0  514.7        (----------*---------) 
S7  -740.5  -207.8  324.9    (----------*---------) 
S8  -729.1  -196.4  336.3    (----------*----------) 
                           -------+---------+---------+---------+-- 
                               -500         0       500      1000 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S6  -314.2   218.5  751.2             (---------*----------) 
S7  -504.0    28.7  561.5         (----------*---------) 
S8  -492.6    40.1  572.9         (----------*---------) 
                           -------+---------+---------+---------+-- 
                               -500         0       500      1000 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S7  -722.5  -189.8  342.9     (---------*----------) 
S8  -711.1  -178.4  354.3     (---------*----------) 
                           -------+---------+---------+---------+-- 
                               -500         0       500      1000 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S8  -521.3    11.4  544.1         (---------*----------) 
                           -------+---------+---------+---------+-- 
















Degradation studies for scaffold S1 
One-way ANOVA: cell conditioned medium at 37°C 
 
Source  DF      SS     MS     F      P 
Factor   2   765.3  382.7  9.04  0.015 
Error    6   254.0   42.3 
Total    8  1019.3 
 
S = 6.506   R-Sq = 75.09%   R-Sq(adj) = 66.78% 
 
 
                                 Individual 95% CIs For Mean Based on 
                                 Pooled StDev 
Level          N    Mean  StDev  ---------+---------+---------+---------+ 
CCM @ 37C  6h  3   80.44  11.27  (--------*---------) 
CCM @ 37C 12h  3  100.00   0.00                      (--------*--------) 
CCM @ 37C 24h  3  100.00   0.00                      (--------*--------) 
                                 ---------+---------+---------+---------+ 
                                         80        90       100       110 
 
Pooled StDev = 6.51 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
CCM @ 37C  6h subtracted from: 
 
               Lower  Center   Upper   -+---------+---------+---------+-------- 
CCM @ 37C 12h  3.260  19.562  35.864                (----------*----------) 
CCM @ 37C 24h  3.260  19.562  35.864                (----------*----------) 
                                       -+---------+---------+---------+-------- 
                                      -15         0        15        30 
 
 
CCM @ 37C 12h subtracted from: 
 
                 Lower  Center   Upper 
CCM @ 37C 24h  -16.302   0.000  16.302 
 
                -+---------+---------+---------+-------- 
CCM @ 37C 24h   (----------*----------) 
                -+---------+---------+---------+-------- 

















One-way ANOVA: DMEM at 37°C   
 
Source  DF      SS     MS      F      P 
Factor   2  1372.1  686.1  17.12  0.003 
Error    6   240.4   40.1 
Total    8  1612.5 
 
S = 6.330   R-Sq = 85.09%   R-Sq(adj) = 80.12% 
 
 
                                   Individual 95% CIs For Mean Based on 
                                   Pooled StDev 
Level            N    Mean  StDev  ---------+---------+---------+---------+ 
DMEM @ 37C  6h   3   70.06   5.48  (------*-------) 
DMEM @ 37C  12h  3   81.31   9.49           (-------*------) 
DMEM @ 37C  24h  3  100.00   0.00                           (------*-------) 
                                   ---------+---------+---------+---------+ 
                                           72        84        96       108 
 
Pooled StDev = 6.33 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
DMEM @ 37C  6h subtracted from: 
 
                  Lower  Center   Upper 
DMEM @ 37C  12h  -4.612  11.249  27.109 
DMEM @ 37C  24h  14.078  29.938  45.799 
 
                 ----+---------+---------+---------+----- 
DMEM @ 37C  12h              (-----*------) 
DMEM @ 37C  24h                      (-----*-----) 
                 ----+---------+---------+---------+----- 
                   -25         0        25        50 
 
 
DMEM @ 37C  12h subtracted from: 
 
                 Lower  Center   Upper 
DMEM @ 37C  24h  2.829  18.689  34.550 
 
                 ----+---------+---------+---------+----- 
DMEM @ 37C  24h                 (-----*------) 
                 ----+---------+---------+---------+----- 












One-way ANOVA: DMEM at room temperature  
 
Source  DF     SS    MS     F      P 
Factor   2   17.0   8.5  0.35  0.715 
Error    6  143.6  23.9 
Total    8  160.6 
 
S = 4.892   R-Sq = 10.56%   R-Sq(adj) = 0.00% 
 
 
                                    Individual 95% CIs For Mean Based on 
                                    Pooled StDev 
Level              N   Mean  StDev   -+---------+---------+---------+-------- 
DMEM room tmp 6h   3  8.718  7.543        (------------*-------------) 
DMEM room tmp 12h  3  9.848  1.488          (-------------*-------------) 
DMEM room tmp 24h  3  6.541  3.562   (-------------*-------------) 
                                     -+---------+---------+---------+-------- 
                                    0.0       5.0      10.0      15.0 
 
Pooled StDev = 4.892 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
DMEM room tmp 6h subtracted from: 
 
                     Lower  Center   Upper 
DMEM room tmp 12h  -11.128   1.131  13.389 
DMEM room tmp 24h  -14.435  -2.177  10.082 
 
                   ---------+---------+---------+---------+ 
DMEM room tmp 12h       (--------------*---------------) 
DMEM room tmp 24h   (--------------*---------------) 
                   ---------+---------+---------+---------+ 
                         -8.0       0.0       8.0      16.0 
 
 
DMEM room tmp 12h subtracted from: 
 
                     Lower  Center  Upper 
DMEM room tmp 24h  -15.566  -3.307  8.951 
 
                   ---------+---------+---------+---------+ 
DMEM room tmp 24h  (--------------*--------------) 
                   ---------+---------+---------+---------+ 












One-way ANOVA: SWF at 37°C  
 
Source  DF      SS      MS      F      P 
Factor   2  6737.5  3368.7  49.58  0.000 
Error    6   407.6    67.9 
Total    8  7145.1 
 
S = 8.243   R-Sq = 94.29%   R-Sq(adj) = 92.39% 
 
 
                                 Individual 95% CIs For Mean Based on 
                                 Pooled StDev 
Level          N    Mean  StDev  -+---------+---------+---------+-------- 
SWF @ 37C 6h   3   33.48  10.10  (---*----) 
SWF @ 37C 12h  3   73.81  10.09                  (----*---) 
SWF @ 37C 24h  3  100.00   0.00                            (----*----) 
                                 -+---------+---------+---------+-------- 
                                 25        50        75       100 
 
Pooled StDev = 8.24 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
SWF @ 37C 6h subtracted from: 
 
                Lower  Center   Upper  ---+---------+---------+---------+------ 
SWF @ 37C 12h  19.680  40.334  60.987                     (-----*----) 
SWF @ 37C 24h  45.867  66.520  87.174                            (-----*-----) 
                                       ---+---------+---------+---------+------ 
                                        -35         0        35        70 
 
 
SWF @ 37C 12h subtracted from: 
 
               Lower  Center   Upper  ---+---------+---------+---------+------ 
SWF @ 37C 24h  5.533  26.186  46.840                 (----*-----) 
                                      ---+---------+---------+---------+------ 


















One-way ANOVA: Data at 6h from all media 
 
Source  DF       SS      MS      F      P 
Factor   3   9878.3  3292.8  41.70  0.000 
Error    8    631.8    79.0 
Total   11  10510.1 
 
S = 8.887   R-Sq = 93.99%   R-Sq(adj) = 91.73% 
 
 
                                     Individual 95% CIs For Mean Based on 
                                     Pooled StDev 
Level             N    Mean   StDev  -+---------+---------+---------+-------- 
CCM @ 37C  6h     3  80.438  11.268                              (----*----) 
DMEM @ 37C  6h    3  70.062   5.484                          (----*----) 
DMEM room tmp 6h  3   8.718   7.543  (---*----) 
SWF @ 37C 6h      3  33.480  10.096            (---*----) 
                                     -+---------+---------+---------+-------- 
                                      0        25        50        75 
 
Pooled StDev = 8.887 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
 
CCM @ 37C  6h subtracted from: 
 
                   Lower  Center   Upper    
DMEM @ 37C  6h    -33.62  -10.38   12.87 
DMEM room tmp 6h  -94.96  -71.72  -48.48 
SWF @ 37C 6h      -70.20  -46.96  -23.72 
 
                  ---------+---------+---------+---------+ 
DMEM @ 37C  6h                (----*----) 
DMEM room tmp 6h  (----*---) 
SWF @ 37C 6h           (----*---) 
                  ---------+---------+---------+---------+ 
                         -50         0        50       100 
 
DMEM @ 37C  6h subtracted from: 
 
                   Lower  Center   Upper 
DMEM room tmp 6h  -84.59  -61.34  -38.10 
SWF @ 37C 6h      -59.82  -36.58  -13.34 
 
                  ---------+---------+---------+---------+ 
DMEM room tmp 6h    (----*---) 
SWF @ 37C 6h             (----*---) 
                  ---------+---------+---------+---------+ 
                         -50         0        50       100 
 
DMEM room tmp 6h subtracted from: 
 
              Lower  Center  Upper  ---------+---------+---------+---------+ 
SWF @ 37C 6h   1.52   24.76  48.00                     (----*----) 
                                    ---------+---------+---------+---------+ 
                                           -50         0        50       100 
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One-way ANOVA: Data at 12h from all media  
 
Source  DF       SS      MS      F      P 
Factor   3  13812.7  4604.2  94.82  0.000 
Error    8    388.4    48.6 
Total   11  14201.1 
 
S = 6.968   R-Sq = 97.26%   R-Sq(adj) = 96.24% 
 
 
                                     Individual 95% CIs For Mean Based on 
                                     Pooled StDev 
Level              N    Mean  StDev  +---------+---------+---------+--------- 
CCM @ 37C 12h      3  100.00   0.00                                (--*--) 
DMEM @ 37C  12h    3   81.31   9.49                          (--*--) 
DMEM room tmp 12h  3    9.85   1.49  (--*--) 
SWF @ 37C 12h      3   73.81  10.09                        (--*--) 
                                     +---------+---------+---------+--------- 
                                     0        30        60        90 
 
Pooled StDev = 6.97 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
 
CCM @ 37C 12h subtracted from: 
 
                     Lower  Center   Upper 
DMEM @ 37C  12h     -36.91  -18.69   -0.46 
DMEM room tmp 12h  -108.38  -90.15  -71.93 
SWF @ 37C 12h       -44.41  -26.19   -7.96 
 
                    --+---------+---------+---------+------- 
DMEM @ 37C  12h                    (--*---) 
DMEM room tmp 12h   (---*---) 
SWF @ 37C 12h                    (---*--) 
                    --+---------+---------+---------+------- 
                   -100       -50         0        50 
 
DMEM @ 37C  12h subtracted from: 
 
                    Lower  Center   Upper 
DMEM room tmp 12h  -89.69  -71.46  -53.24 
SWF @ 37C 12h      -25.72   -7.50   10.73 
 
                    --+---------+---------+---------+------- 
DMEM room tmp 12h       (---*--) 
SWF @ 37C 12h                        (---*--) 
                    --+---------+---------+---------+------- 
                   -100       -50         0        50 
 
DMEM room tmp 12h subtracted from: 
 
               Lower  Center  Upper   --+---------+---------+---------+------- 
SWF @ 37C 12h  45.74   63.97  82.19                                  (---*--) 
                                      --+---------+---------+---------+------- 
                                     -100       -50         0        50 
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One-way ANOVA: Data at 24h from all media 
 
Source  DF        SS       MS        F      P 
Factor   3  19652.72  6550.91  2065.00  0.000 
Error    8     25.38     3.17 
Total   11  19678.10 
 
S = 1.781   R-Sq = 99.87%   R-Sq(adj) = 99.82% 
 
 
                                     Individual 95% CIs For Mean Based on 
                                     Pooled StDev 
Level              N    Mean  StDev  --------+---------+---------+---------+- 
CCM @ 37C 24h      3  100.00   0.00                                       (*) 
DMEM @ 37C  24h    3  100.00   0.00                                       (*) 
DMEM room tmp 24h  3    6.54   3.56  (*) 
SWF @ 37C 24h      3  100.00   0.00                                       (*) 
                                     --------+---------+---------+---------+- 
                                            25        50        75       100 
Pooled StDev = 1.78 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
CCM @ 37C 24h subtracted from: 
 
                    Lower  Center   Upper 
DMEM @ 37C  24h     -4.66    0.00    4.66 
DMEM room tmp 24h  -98.12  -93.46  -88.80 
SWF @ 37C 24h       -4.66    0.00    4.66 
 
                      +---------+---------+---------+--------- 
DMEM @ 37C  24h                          (*) 
DMEM room tmp 24h     (*) 
SWF @ 37C 24h                            (*) 
                      +---------+---------+---------+--------- 
                   -100       -50         0        50 
 
DMEM @ 37C  24h subtracted from: 
 
                    Lower  Center   Upper 
DMEM room tmp 24h  -98.12  -93.46  -88.80 
SWF @ 37C 24h       -4.66    0.00    4.66 
 
                      +---------+---------+---------+--------- 
DMEM room tmp 24h     (*) 
SWF @ 37C 24h                            (*) 
                      +---------+---------+---------+--------- 
                   -100       -50         0        50 
 
DMEM room tmp 24h subtracted from: 
 
               Lower  Center  Upper 
SWF @ 37C 24h  88.80   93.46  98.12 
 
                  +---------+---------+---------+--------- 
SWF @ 37C 24h                                           (*) 
                  +---------+---------+---------+--------- 
               -100       -50         0        50 
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Degradation studies for scaffold S5 
One-way ANOVA: Cell conditioned medium at 37°C 
 
Source  DF       SS      MS       F      P 
Factor   2  1092.70  546.35  166.19  0.000 
Error    6    19.73    3.29 
Total    8  1112.42 
 
S = 1.813   R-Sq = 98.23%   R-Sq(adj) = 97.64% 
 
 
                           Individual 95% CIs For Mean Based on 
                           Pooled StDev 
Level    N    Mean  StDev  -------+---------+---------+---------+-- 
CCM 6h   3   76.63   3.14  (--*--) 
CCM 12h  3  100.00   0.00                               (--*--) 
CCM 24h  3  100.00   0.00                               (--*--) 
                           -------+---------+---------+---------+-- 
                               80.0      88.0      96.0     104.0 
 
Pooled StDev = 1.81 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
CCM 6h subtracted from: 
 
          Lower  Center   Upper  -----+---------+---------+---------+---- 
CCM 12h  18.831  23.374  27.917                          (---*----) 
CCM 24h  18.831  23.374  27.917                          (---*----) 
                                 -----+---------+---------+---------+---- 
                                      0        10        20        30 
 
 
CCM 12h subtracted from: 
 
          Lower  Center  Upper  -----+---------+---------+---------+---- 
CCM 24h  -4.543   0.000  4.543  (----*----) 
                                -----+---------+---------+---------+---- 

















One-way ANOVA: DMEM at 37°C   
 
Source  DF    SS    MS      F      P 
Factor   2  7014  3507  13.76  0.006 
Error    6  1529   255 
Total    8  8543 
 
S = 15.96   R-Sq = 82.10%   R-Sq(adj) = 76.14% 
 
 
                                   Individual 95% CIs For Mean Based on 
                                   Pooled StDev 
Level            N    Mean  StDev  -----+---------+---------+---------+---- 
DMEM @ 37C  6h   3   37.52   9.95  (-------*------) 
DMEM @ 37C  12h  3   44.69  25.80    (-------*------) 
DMEM @ 37C  24h  3  100.00   0.00                       (------*-------) 
                                   -----+---------+---------+---------+---- 
                                       30        60        90       120 
 
Pooled StDev = 15.96 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
DMEM @ 37C  6h subtracted from: 
 
                  Lower  Center   Upper 
DMEM @ 37C  12h  -32.83    7.17   47.17 
DMEM @ 37C  24h   22.48   62.48  102.48 
 
                 ---------+---------+---------+---------+ 
DMEM @ 37C  12h              (-------*-------) 
DMEM @ 37C  24h                         (-------*-------) 
                 ---------+---------+---------+---------+ 
                        -50         0        50       100 
 
 
DMEM @ 37C  12h subtracted from: 
 
                 Lower  Center  Upper  ---------+---------+---------+---------+ 
DMEM @ 37C  24h  15.31   55.31  95.31                        (-------*-------) 
                                       ---------+---------+---------+---------+ 















One-way ANOVA: DMEM at room temperature 
 
Source  DF     SS    MS     F      P 
Factor   2   88.0  44.0  0.72  0.524 
Error    6  366.2  61.0 
Total    8  454.2 
 
S = 7.812   R-Sq = 19.38%   R-Sq(adj) = 0.00% 
 
 
                                      Individual 95% CIs For Mean Based on 
                                      Pooled StDev 
Level              N    Mean   StDev  -------+---------+---------+---------+-- 
DMEM room tmp 6h   3  13.705  10.047  (-------------*-------------) 
DMEM room tmp 12h  3  16.939   9.025      (-------------*-------------) 
DMEM room tmp 24h  3  21.337   0.829            (-------------*------------) 
                                      -------+---------+---------+---------+-- 
                                           8.0      16.0      24.0      32.0 
 
Pooled StDev = 7.812 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
DMEM room tmp 6h subtracted from: 
 
                     Lower  Center   Upper 
DMEM room tmp 12h  -16.342   3.234  22.809 
DMEM room tmp 24h  -11.943   7.632  27.207 
 
                   ------+---------+---------+---------+--- 
DMEM room tmp 12h       (------------*------------) 
DMEM room tmp 24h          (------------*------------) 
                   ------+---------+---------+---------+--- 
                       -15         0        15        30 
 
 
DMEM room tmp 12h subtracted from: 
 
                     Lower  Center   Upper 
DMEM room tmp 24h  -15.177   4.398  23.974 
 
                   ------+---------+---------+---------+--- 
DMEM room tmp 24h        (------------*------------) 
                   ------+---------+---------+---------+--- 












One-way ANOVA: SWF at 37°C  
 
Source  DF      SS      MS       F      P 
Factor   2  7509.6  3754.8  187.64  0.000 
Error    6   120.1    20.0 
Total    8  7629.7 
 
S = 4.473   R-Sq = 98.43%   R-Sq(adj) = 97.90% 
 
 
                                 Individual 95% CIs For Mean Based on 
                                 Pooled StDev 
Level          N    Mean  StDev   +---------+---------+---------+--------- 
SWF @ 37C 6h   3   30.35   4.69   (-*--) 
SWF @ 37C 12h  3   54.39   6.17            (--*-) 
SWF @ 37C 24h  3  100.00   0.00                              (--*--) 
                                  +---------+---------+---------+--------- 
                                 25        50        75       100 
 
Pooled StDev = 4.47 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 97.80% 
 
 
SWF @ 37C 6h subtracted from: 
 
                Lower  Center   Upper  ------+---------+---------+---------+--- 
SWF @ 37C 12h  12.831  24.040  35.249                      (--*--) 
SWF @ 37C 24h  58.443  69.651  80.860                                   (--*--) 
                                       ------+---------+---------+---------+--- 
                                           -35         0        35        70 
 
 
SWF @ 37C 12h subtracted from: 
 
                Lower  Center   Upper  ------+---------+---------+---------+--- 
SWF @ 37C 24h  34.403  45.611  56.820                            (--*--) 
                                       ------+---------+---------+---------+--- 


















One-way ANOVA: Data at 6h from all media 
 
Source  DF      SS      MS      F      P 
Factor   3  6394.0  2131.3  36.77  0.000 
Error    8   463.8    58.0 
Total   11  6857.8 
 
S = 7.614   R-Sq = 93.24%   R-Sq(adj) = 90.70% 
 
 
                                     Individual 95% CIs For Mean Based on 
                                     Pooled StDev 
Level             N    Mean   StDev  ---------+---------+---------+---------+ 
CCM 6h            3  76.626   3.140                            (---*---) 
DMEM @ 37C  6h    3  37.523   9.953            (---*---) 
DMEM room tmp 6h  3  13.705  10.047  (---*----) 
SWF @ 37C 6h      3  30.349   4.692         (---*---) 
                                     ---------+---------+---------+---------+ 
                                             25        50        75       100 
 
Pooled StDev = 7.614 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
CCM 6h subtracted from: 
 
                    Lower   Center    Upper 
DMEM @ 37C  6h    -59.016  -39.102  -19.189 
DMEM room tmp 6h  -82.834  -62.921  -43.007 
SWF @ 37C 6h      -66.190  -46.277  -26.364 
 
                  ----+---------+---------+---------+----- 
DMEM @ 37C  6h           (-----*-----) 
DMEM room tmp 6h  (-----*-----) 
SWF @ 37C 6h           (-----*----) 
                  ----+---------+---------+---------+----- 
                    -70       -35         0        35 
 
DMEM @ 37C  6h subtracted from: 
 
                    Lower   Center   Upper 
DMEM room tmp 6h  -43.732  -23.818  -3.905 
SWF @ 37C 6h      -27.088   -7.175  12.739 
 
                  ----+---------+---------+---------+----- 
DMEM room tmp 6h              (----*-----) 
SWF @ 37C 6h                      (-----*-----) 
                  ----+---------+---------+---------+----- 
                    -70       -35         0        35 
 
 
DMEM room tmp 6h subtracted from: 
 
               Lower  Center   Upper  ----+---------+---------+---------+----- 
SWF @ 37C 6h  -3.270  16.643  36.557                         (-----*----) 
                                      ----+---------+---------+---------+----- 




One-way ANOVA: Data at 12 h from all media 
 
Source  DF     SS    MS      F      P 
Factor   3  10729  3576  18.23  0.001 
Error    8   1570   196 
Total   11  12299 
 
S = 14.01   R-Sq = 87.24%   R-Sq(adj) = 82.45% 
 
 
                                     Individual 95% CIs For Mean Based on 
                                     Pooled StDev 
Level              N    Mean  StDev  +---------+---------+---------+--------- 
CCM 12h            3  100.00   0.00                         (-----*----) 
DMEM @ 37C  12h    3   44.69  25.80         (-----*----) 
DMEM room tmp 12h  3   16.94   9.03  (----*----) 
SWF @ 37C 12h      3   54.39   6.17            (-----*----) 
                                     +---------+---------+---------+--------- 
                                     0        35        70       105 
Pooled StDev = 14.01 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
CCM 12h subtracted from: 
 
                     Lower  Center   Upper 
DMEM @ 37C  12h     -91.94  -55.31  -18.67 
DMEM room tmp 12h  -119.70  -83.06  -46.43 
SWF @ 37C 12h       -82.25  -45.61   -8.98 
 
                   ----+---------+---------+---------+----- 
DMEM @ 37C  12h          (------*------) 
DMEM room tmp 12h  (------*-------) 
SWF @ 37C 12h              (------*------) 
                   ----+---------+---------+---------+----- 
                    -100       -50         0        50 
 
DMEM @ 37C  12h subtracted from: 
 
                    Lower  Center  Upper 
DMEM room tmp 12h  -64.39  -27.75   8.88 
SWF @ 37C 12h      -26.94    9.70  46.33 
 
                   ----+---------+---------+---------+----- 
DMEM room tmp 12h             (------*-------) 
SWF @ 37C 12h                         (------*------) 
                   ----+---------+---------+---------+----- 
                    -100       -50         0        50 
 
 
DMEM room tmp 12h subtracted from: 
 
               Lower  Center  Upper  ----+---------+---------+---------+----- 
SWF @ 37C 12h   0.81   37.45  74.09                          (------*-------) 
                                     ----+---------+---------+---------+----- 




One-way ANOVA: Data at 24h from all media 
 
Source  DF        SS       MS         F      P 
Factor   3  13922.63  4640.88  27025.15  0.000 
Error    8      1.37     0.17 
Total   11  13924.01 
 




Level              N     Mean  StDev 
CCM 24h            3  100.000  0.000 
DMEM @ 37C  24h    3  100.000  0.000 
DMEM room tmp 24h  3   21.337  0.829 
SWF @ 37C 24h      3  100.000  0.000 
 
                   Individual 95% CIs For Mean Based on Pooled StDev 
Level               +---------+---------+---------+--------- 
CCM 24h                                                     * 
DMEM @ 37C  24h                                             * 
DMEM room tmp 24h   (* 
SWF @ 37C 24h                                               * 
                    +---------+---------+---------+--------- 
                   20        40        60        80 
 
Pooled StDev = 0.414 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 98.74% 
 
 
CCM 24h subtracted from: 
 
                     Lower   Center    Upper 
DMEM @ 37C  24h     -1.084    0.000    1.084 
DMEM room tmp 24h  -79.747  -78.663  -77.579 
SWF @ 37C 24h       -1.084    0.000    1.084 
 
                     +---------+---------+---------+--------- 
DMEM @ 37C  24h                          * 
DMEM room tmp 24h    *) 
SWF @ 37C 24h                            * 
                     +---------+---------+---------+--------- 
                   -80       -40         0        40 
 
 
DMEM @ 37C  24h subtracted from: 
 
                     Lower   Center    Upper 
DMEM room tmp 24h  -79.747  -78.663  -77.579 
SWF @ 37C 24h       -1.084    0.000    1.084 
 
                     +---------+---------+---------+--------- 
DMEM room tmp 24h    *) 
SWF @ 37C 24h                            * 
                     +---------+---------+---------+--------- 





DMEM room tmp 24h subtracted from: 
 
                Lower  Center   Upper 
SWF @ 37C 24h  77.579  78.663  79.747 
 
                 +---------+---------+---------+--------- 
SWF @ 37C 24h                                           (* 
                 +---------+---------+---------+--------- 








































Appendix B (Data for the non-crosslinked scaffolds) 
 
One-way ANOVA: fiber diameter 
 
Source   DF       SS     MS     F      P 
Factor    7   216.75  30.96  8.92  0.000 
Error   232   805.50   3.47 
Total   239  1022.25 
 
S = 1.863   R-Sq = 21.20%   R-Sq(adj) = 18.83% 
 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level   N   Mean  StDev  ---------+---------+---------+---------+ 
S1     30  3.149  0.721  (----*-----) 
S2     30  4.854  1.635                (----*-----) 
S3     30  4.067  1.153         (-----*----) 
S4     30  3.950  1.561        (-----*-----) 
S5     30  3.204  0.902  (-----*----) 
S6     30  4.122  1.335          (----*-----) 
S7     30  5.892  1.879                         (----*-----) 
S8     30  5.594  3.833                      (-----*----) 
                         ---------+---------+---------+---------+ 
                                3.6       4.8       6.0       7.2 
 
Pooled StDev = 1.863 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.75% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S2   0.232   1.705  3.178                    (-----*-----) 
S3  -0.555   0.918  2.391                 (-----*-----) 
S4  -0.672   0.801  2.274                (-----*-----) 
S5  -1.418   0.055  1.528             (-----*-----) 
S6  -0.501   0.972  2.445                 (-----*-----) 
S7   1.270   2.743  4.216                        (-----*-----) 
S8   0.971   2.444  3.917                       (-----*-----) 
                           -------+---------+---------+---------+-- 
                               -2.5       0.0       2.5       5.0 
 
 
S2 subtracted from: 
 
     Lower  Center   Upper  -------+---------+---------+---------+-- 
S3  -2.260  -0.787   0.686          (-----*-----) 
S4  -2.377  -0.904   0.569         (-----*-----) 
S5  -3.123  -1.650  -0.177       (----*-----) 
S6  -2.206  -0.733   0.740          (-----*-----) 
S7  -0.435   1.038   2.511                 (-----*-----) 
S8  -0.734   0.739   2.212                (-----*-----) 
                            -------+---------+---------+---------+-- 
                                -2.5       0.0       2.5       5.0 
82 
 
S3 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S4  -1.590  -0.117  1.356             (-----*----) 
S5  -2.336  -0.863  0.610          (-----*----) 
S6  -1.419   0.054  1.527             (-----*-----) 
S7   0.352   1.825  3.298                    (-----*-----) 
S8   0.053   1.526  2.999                   (-----*-----) 
                           -------+---------+---------+---------+-- 
                               -2.5       0.0       2.5       5.0 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S5  -2.219  -0.746  0.727          (-----*-----) 
S6  -1.301   0.172  1.645              (-----*-----) 
S7   0.469   1.942  3.415                     (-----*-----) 
S8   0.171   1.644  3.117                    (-----*----) 
                           -------+---------+---------+---------+-- 
                               -2.5       0.0       2.5       5.0 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S6  -0.556   0.917  2.390                 (-----*-----) 
S7   1.215   2.688  4.161                        (-----*-----) 
S8   0.916   2.389  3.862                       (-----*----) 
                           -------+---------+---------+---------+-- 
                               -2.5       0.0       2.5       5.0 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S7   0.297   1.770  3.243                    (-----*-----) 
S8  -0.001   1.472  2.945                   (-----*-----) 
                           -------+---------+---------+---------+-- 
                               -2.5       0.0       2.5       5.0 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  -------+---------+---------+---------+-- 
S8  -1.771  -0.298  1.175            (-----*-----) 
                           -------+---------+---------+---------+-- 










One-way ANOVA: Stress 
 
Source  DF      SS     MS     F      P 
Factor   7   5.901  0.843  2.01  0.078 
Error   40  16.791  0.420 
Total   47  22.692 
 
S = 0.6479   R-Sq = 26.01%   R-Sq(adj) = 13.06% 
 
 
                          Individual 95% CIs For Mean Based on 
                          Pooled StDev 
Level  N    Mean   StDev   -+---------+---------+---------+-------- 
S1     6  1.1363  0.3192    (--------*--------) 
S2     6  1.6463  1.0160             (-------*--------) 
S3     6  1.9223  1.1277                 (--------*--------) 
S4     6  1.0628  0.3230   (--------*--------) 
S5     6  1.3990  0.5784        (--------*--------) 
S6     6  1.9073  0.5189                 (--------*--------) 
S7     6  2.0873  0.3356                    (--------*--------) 
S8     6  1.5490  0.3629           (--------*--------) 
                           -+---------+---------+---------+-------- 
                          0.60      1.20      1.80      2.40 
 
Pooled StDev = 0.6479 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S2  -0.6856   0.5100  1.7056               (---------*---------) 
S3  -0.4096   0.7860  1.9816                  (---------*---------) 
S4  -1.2691  -0.0735  1.1221          (---------*---------) 
S5  -0.9329   0.2627  1.4582             (---------*---------) 
S6  -0.4246   0.7710  1.9666                 (---------*---------) 
S7  -0.2446   0.9510  2.1466                   (---------*---------) 
S8  -0.7829   0.4127  1.6082              (---------*---------) 
                              ---------+---------+---------+---------+ 
                                    -1.2       0.0       1.2       2.4 
 
 
S2 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S3  -0.9196   0.2760  1.4716             (---------*---------) 
S4  -1.7791  -0.5835  0.6121      (---------*---------) 
S5  -1.4429  -0.2473  0.9482         (---------*---------) 
S6  -0.9346   0.2610  1.4566             (---------*---------) 
S7  -0.7546   0.4410  1.6366               (---------*---------) 
S8  -1.2929  -0.0973  1.0982          (---------*---------) 
                              ---------+---------+---------+---------+ 






S3 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S4  -2.0551  -0.8595  0.3361    (---------*---------) 
S5  -1.7189  -0.5233  0.6722       (---------*---------) 
S6  -1.2106  -0.0150  1.1806           (---------*---------) 
S7  -1.0306   0.1650  1.3606            (---------*---------) 
S8  -1.5689  -0.3733  0.8222        (---------*---------) 
                              ---------+---------+---------+---------+ 
                                    -1.2       0.0       1.2       2.4 
 
 
S4 subtracted from: 
 
      Lower  Center   Upper  ---------+---------+---------+---------+ 
S5  -0.8594  0.3362  1.5317              (---------*---------) 
S6  -0.3511  0.8445  2.0401                  (---------*---------) 
S7  -0.1711  1.0245  2.2201                    (---------*---------) 
S8  -0.7094  0.4862  1.6817               (---------*---------) 
                             ---------+---------+---------+---------+ 
                                   -1.2       0.0       1.2       2.4 
 
 
S5 subtracted from: 
 
      Lower  Center   Upper  ---------+---------+---------+---------+ 
S6  -0.6872  0.5083  1.7039               (---------*---------) 
S7  -0.5072  0.6883  1.8839                 (---------*---------) 
S8  -1.0456  0.1500  1.3456            (---------*---------) 
                             ---------+---------+---------+---------+ 
                                   -1.2       0.0       1.2       2.4 
 
 
S6 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S7  -1.0156   0.1800  1.3756             (---------*--------) 
S8  -1.5539  -0.3583  0.8372        (---------*---------) 
                              ---------+---------+---------+---------+ 
                                    -1.2       0.0       1.2       2.4 
 
 
S7 subtracted from: 
 
      Lower   Center   Upper  ---------+---------+---------+---------+ 
S8  -1.7339  -0.5383  0.6572       (---------*--------) 
                              ---------+---------+---------+---------+ 










One-way ANOVA: Strain 
 
Source  DF        SS        MS     F      P 
Factor   7  0.003182  0.000455  2.04  0.073 
Error   40  0.008901  0.000223 
Total   47  0.012083 
 
S = 0.01492   R-Sq = 26.34%   R-Sq(adj) = 13.44% 
 
 
                            Individual 95% CIs For Mean Based on 
                            Pooled StDev 
Level  N     Mean    StDev  --------+---------+---------+---------+- 
S1     6  0.02833  0.00665           (-------*-------) 
S2     6  0.03967  0.03828                  (-------*--------) 
S3     6  0.02250  0.00723       (-------*-------) 
S4     6  0.01767  0.00745    (-------*-------) 
S5     6  0.02250  0.00509       (-------*-------) 
S6     6  0.03667  0.00845                (-------*--------) 
S7     6  0.02750  0.00606          (-------*--------) 
S8     6  0.01467  0.00539  (-------*-------) 
                            --------+---------+---------+---------+- 
                                  0.015     0.030     0.045     0.060 
 
Pooled StDev = 0.01492 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S2  -0.01619   0.01133  0.03886               (--------*--------) 
S3  -0.03336  -0.00583  0.02169         (--------*--------) 
S4  -0.03819  -0.01067  0.01686       (--------*---------) 
S5  -0.03336  -0.00583  0.02169         (--------*--------) 
S6  -0.01919   0.00833  0.03586              (--------*--------) 
S7  -0.02836  -0.00083  0.02669           (--------*--------) 
S8  -0.04119  -0.01367  0.01386      (--------*---------) 
                                 --------+---------+---------+---------+- 
                                      -0.030     0.000     0.030     0.060 
 
 
S2 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S3  -0.04469  -0.01717  0.01036     (--------*--------) 
S4  -0.04953  -0.02200  0.00553   (---------*--------) 
S5  -0.04469  -0.01717  0.01036     (--------*--------) 
S6  -0.03053  -0.00300  0.02453          (--------*--------) 
S7  -0.03969  -0.01217  0.01536       (--------*--------) 
S8  -0.05253  -0.02500  0.00253  (---------*--------) 
                                 --------+---------+---------+---------+- 






S3 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S4  -0.03236  -0.00483  0.02269         (--------*---------) 
S5  -0.02753   0.00000  0.02753           (--------*--------) 
S6  -0.01336   0.01417  0.04169                (--------*--------) 
S7  -0.02253   0.00500  0.03253            (---------*--------) 
S8  -0.03536  -0.00783  0.01969        (--------*---------) 
                                 --------+---------+---------+---------+- 
                                      -0.030     0.000     0.030     0.060 
 
 
S4 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S5  -0.02269   0.00483  0.03236            (---------*--------) 
S6  -0.00853   0.01900  0.04653                 (--------*---------) 
S7  -0.01769   0.00983  0.03736              (--------*--------) 
S8  -0.03053  -0.00300  0.02453          (--------*--------) 
                                 --------+---------+---------+---------+- 
                                      -0.030     0.000     0.030     0.060 
 
 
S5 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S6  -0.01336   0.01417  0.04169                (--------*--------) 
S7  -0.02253   0.00500  0.03253            (---------*--------) 
S8  -0.03536  -0.00783  0.01969        (--------*---------) 
                                 --------+---------+---------+---------+- 
                                      -0.030     0.000     0.030     0.060 
 
 
S6 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S7  -0.03669  -0.00917  0.01836        (--------*--------) 
S8  -0.04953  -0.02200  0.00553   (---------*--------) 
                                 --------+---------+---------+---------+- 
                                      -0.030     0.000     0.030     0.060 
 
 
S7 subtracted from: 
 
       Lower    Center    Upper  --------+---------+---------+---------+- 
S8  -0.04036  -0.01283  0.01469       (--------*--------) 
                                 --------+---------+---------+---------+- 













One-way ANOVA: Modulus 
 
Source  DF     SS    MS     F      P 
Factor   7  18245  2606  3.25  0.008 
Error   40  32095   802 
Total   47  50340 
 
S = 28.33   R-Sq = 36.24%   R-Sq(adj) = 25.09% 
 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level  N    Mean  StDev  --+---------+---------+---------+------- 
S1     6   47.13   6.46  (-------*-------) 
S2     6   93.64  46.67                 (-------*-------) 
S3     6   99.28  45.64                   (-------*-------) 
S4     6   64.84  15.30        (-------*------) 
S5     6   80.52  20.33             (-------*-------) 
S6     6   66.58  18.81        (-------*-------) 
S7     6  104.84  18.74                     (-------*-------) 
S8     6  100.32  27.64                    (------*-------) 
                         --+---------+---------+---------+------- 
                          30        60        90       120 
 
Pooled StDev = 28.33 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
     Lower  Center   Upper  -----+---------+---------+---------+---- 
S2   -5.77   46.50   98.77                (--------*-------) 
S3   -0.13   52.14  104.41                 (--------*-------) 
S4  -34.56   17.71   69.98           (--------*--------) 
S5  -18.88   33.39   85.66              (--------*-------) 
S6  -32.82   19.45   71.72            (-------*--------) 
S7    5.43   57.70  109.97                  (--------*-------) 
S8    0.92   53.19  105.46                 (--------*--------) 
                            -----+---------+---------+---------+---- 
                               -60         0        60       120 
 
 
S2 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S3  -46.63    5.64  57.91         (--------*--------) 
S4  -81.07  -28.80  23.47   (--------*--------) 
S5  -65.38  -13.11  39.16      (--------*--------) 
S6  -79.33  -27.06  25.21    (-------*--------) 
S7  -41.07   11.20  63.47          (--------*--------) 
S8  -45.59    6.68  58.95         (--------*--------) 
                           -----+---------+---------+---------+---- 






S3 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S4  -86.71  -34.44  17.83   (-------*--------) 
S5  -71.02  -18.75  33.52     (--------*--------) 
S6  -84.97  -32.70  19.57   (--------*-------) 
S7  -46.71    5.56  57.83         (--------*--------) 
S8  -51.23    1.04  53.31        (--------*--------) 
                           -----+---------+---------+---------+---- 
                              -60         0        60       120 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S5  -36.59   15.68  67.95           (--------*-------) 
S6  -50.53    1.74  54.01         (-------*--------) 
S7  -12.28   39.99  92.26               (--------*-------) 
S8  -16.79   35.48  87.75              (--------*--------) 
                           -----+---------+---------+---------+---- 
                              -60         0        60       120 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S6  -66.21  -13.94  38.33      (--------*-------) 
S7  -27.96   24.31  76.58            (--------*--------) 
S8  -32.48   19.79  72.06            (-------*--------) 
                           -----+---------+---------+---------+---- 
                              -60         0        60       120 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S7  -14.01   38.26  90.53               (-------*--------) 
S8  -18.53   33.74  86.01              (--------*-------) 
                           -----+---------+---------+---------+---- 
                              -60         0        60       120 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  -----+---------+---------+---------+---- 
S8  -56.79   -4.52  47.75        (-------*--------) 
                           -----+---------+---------+---------+---- 













Appendix C (Data for the scaffolds crosslinked by the vapor method) 
 
SEM images (The scale bar in all the images is 10 µm) 
 
     
 
     
 
     
 











































































































One-way ANOVA: fiber diameter 
 
Source   DF       SS      MS      F      P 
Factor    7   728.15  104.02  27.89  0.000 
Error   232   865.31    3.73 
Total   239  1593.46 
 
S = 1.931   R-Sq = 45.70%   R-Sq(adj) = 44.06% 
 
 
                         Individual 95% CIs For Mean Based on 
                         Pooled StDev 
Level   N   Mean  StDev  -------+---------+---------+---------+-- 
S1     30  3.666  1.287    (--*---) 
S2     30  4.845  1.928          (--*---) 
S3     30  3.727  1.318    (---*--) 
S4     30  3.970  1.214     (---*--) 
S5     30  4.486  1.481        (--*---) 
S6     30  3.235  1.186  (--*---) 
S7     30  8.360  3.047                           (---*--) 
S8     30  7.268  2.894                      (--*---) 
                         -------+---------+---------+---------+-- 
                              4.0       6.0       8.0      10.0 
 
Pooled StDev = 1.931 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.75% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S2  -0.348   1.179  2.706                    (---*----) 
S3  -1.466   0.060  1.587                 (---*----) 
S4  -1.223   0.304  1.830                  (---*---) 
S5  -0.707   0.820  2.346                   (---*----) 
S6  -1.958  -0.431  1.095               (----*---) 
S7   3.167   4.694  6.220                              (---*----) 
S8   2.075   3.601  5.128                           (---*----) 
                           ---------+---------+---------+---------+ 
                                 -3.5       0.0       3.5       7.0 
 
 
S2 subtracted from: 
 
     Lower  Center   Upper  ---------+---------+---------+---------+ 
S3  -2.645  -1.119   0.408             (----*---) 
S4  -2.402  -0.875   0.651              (---*----) 
S5  -1.886  -0.359   1.167                (---*---) 
S6  -3.137  -1.610  -0.084            (---*----) 
S7   1.988   3.515   5.041                           (---*---) 
S8   0.896   2.422   3.949                        (---*---) 
                            ---------+---------+---------+---------+ 






S3 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S4  -1.283   0.243  1.770                 (----*---) 
S5  -0.767   0.759  2.286                   (---*----) 
S6  -2.018  -0.492  1.035               (----*---) 
S7   3.107   4.633  6.160                              (---*----) 
S8   2.014   3.541  5.068                           (---*---) 
                           ---------+---------+---------+---------+ 
                                 -3.5       0.0       3.5       7.0 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S5  -1.011   0.516  2.043                  (---*----) 
S6  -2.262  -0.735  0.792               (---*---) 
S7   2.863   4.390  5.917                             (----*---) 
S8   1.771   3.298  4.824                          (---*----) 
                           ---------+---------+---------+---------+ 
                                 -3.5       0.0       3.5       7.0 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S6  -2.778  -1.251  0.276             (---*----) 
S7   2.347   3.874  5.401                            (---*---) 
S8   1.255   2.782  4.308                         (---*---) 
                           ---------+---------+---------+---------+ 
                                 -3.5       0.0       3.5       7.0 
 
 
S6 subtracted from: 
 
    Lower  Center  Upper  ---------+---------+---------+---------+ 
S7  3.598   5.125  6.652                               (----*---) 
S8  2.506   4.033  5.559                            (----*---) 
                          ---------+---------+---------+---------+ 
                                -3.5       0.0       3.5       7.0 
 
 
S7 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S8  -2.619  -1.092  0.434              (---*---) 
                           ---------+---------+---------+---------+ 















One-way ANOVA: Stress 
 
Source  DF      SS     MS     F      P 
Factor   7   4.406  0.629  3.91  0.002 
Error   40   6.437  0.161 
Total   47  10.843 
 
S = 0.4011   R-Sq = 40.64%   R-Sq(adj) = 30.25% 
 
 
                          Individual 95% CIs For Mean Based on 
                          Pooled StDev 
Level  N    Mean   StDev  --+---------+---------+---------+------- 
S1     6  1.1302  0.4865          (------*-----) 
S2     6  1.7692  0.4763                       (-----*------) 
S3     6  1.2947  0.3091             (------*------) 
S4     6  1.3357  0.6963              (------*-----) 
S5     6  0.9598  0.2757       (-----*------) 
S6     6  0.7283  0.1873  (------*-----) 
S7     6  0.8755  0.1609     (------*-----) 
S8     6  1.0722  0.3263         (-----*------) 
                          --+---------+---------+---------+------- 
                          0.50      1.00      1.50      2.00 
 
Pooled StDev = 0.4011 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
      Lower   Center   Upper  --------+---------+---------+---------+- 
S2  -0.1012   0.6390  1.3792                   (------*-------) 
S3  -0.5757   0.1645  0.9047              (-------*------) 
S4  -0.5347   0.2055  0.9457               (------*------) 
S5  -0.9106  -0.1703  0.5699           (------*-------) 
S6  -1.1421  -0.4018  0.3384         (------*------) 
S7  -0.9949  -0.2547  0.4856          (------*-------) 
S8  -0.7982  -0.0580  0.6822            (------*-------) 
                              --------+---------+---------+---------+- 
                                   -1.0       0.0       1.0       2.0 
 
 
S2 subtracted from: 
 
      Lower   Center    Upper  --------+---------+---------+---------+- 
S3  -1.2147  -0.4745   0.2657        (------*-------) 
S4  -1.1737  -0.4335   0.3067        (-------*------) 
S5  -1.5496  -0.8093  -0.0691     (------*------) 
S6  -1.7811  -1.0408  -0.3006  (-------*------) 
S7  -1.6339  -0.8937  -0.1534    (------*------) 
S8  -1.4372  -0.6970   0.0432      (------*------) 
                               --------+---------+---------+---------+- 






S3 subtracted from: 
 
      Lower   Center   Upper  --------+---------+---------+---------+- 
S4  -0.6992   0.0410  0.7812             (------*-------) 
S5  -1.0751  -0.3348  0.4054         (-------*------) 
S6  -1.3066  -0.5663  0.1739       (------*-------) 
S7  -1.1594  -0.4192  0.3211        (-------*------) 
S8  -0.9627  -0.2225  0.5177          (-------*------) 
                              --------+---------+---------+---------+- 
                                   -1.0       0.0       1.0       2.0 
 
 
S4 subtracted from: 
 
      Lower   Center   Upper  --------+---------+---------+---------+- 
S5  -1.1161  -0.3758  0.3644         (------*-------) 
S6  -1.3476  -0.6073  0.1329       (------*------) 
S7  -1.2004  -0.4602  0.2801        (------*-------) 
S8  -1.0037  -0.2635  0.4767          (------*-------) 
                              --------+---------+---------+---------+- 
                                   -1.0       0.0       1.0       2.0 
 
 
S5 subtracted from: 
 
      Lower   Center   Upper  --------+---------+---------+---------+- 
S6  -0.9717  -0.2315  0.5087          (-------*------) 
S7  -0.8246  -0.0843  0.6559            (------*-------) 
S8  -0.6279   0.1123  0.8526              (------*-------) 
                              --------+---------+---------+---------+- 
                                   -1.0       0.0       1.0       2.0 
 
 
S6 subtracted from: 
 
      Lower  Center   Upper  --------+---------+---------+---------+- 
S7  -0.5931  0.1472  0.8874              (------*-------) 
S8  -0.3964  0.3438  1.0841                (------*-------) 
                             --------+---------+---------+---------+- 
                                  -1.0       0.0       1.0       2.0 
 
 
S7 subtracted from: 
 
      Lower  Center   Upper  --------+---------+---------+---------+- 
S8  -0.5436  0.1967  0.9369               (------*------) 
                             --------+---------+---------+---------+- 















One-way ANOVA: Strain 
 
Source  DF        SS        MS     F      P 
Factor   7  0.006165  0.000881  4.14  0.002 
Error   40  0.008512  0.000213 
Total   47  0.014677 
 
S = 0.01459   R-Sq = 42.01%   R-Sq(adj) = 31.86% 
 
 
                            Individual 95% CIs For Mean Based on 
                            Pooled StDev 
Level  N     Mean    StDev  ------+---------+---------+---------+--- 
S1     6  0.05033  0.02170                        (-------*-------) 
S2     6  0.04467  0.02491                    (-------*-------) 
S3     6  0.02800  0.00876         (-------*-------) 
S4     6  0.02233  0.00769     (-------*-------) 
S5     6  0.02800  0.00699         (-------*-------) 
S6     6  0.04650  0.01875                     (-------*-------) 
S7     6  0.02967  0.00592          (-------*-------) 
S8     6  0.01767  0.00631  (-------*-------) 
                            ------+---------+---------+---------+--- 
                                0.015     0.030     0.045     0.060 
 
Pooled StDev = 0.01459 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
       Lower    Center     Upper     +---------+---------+---------+--------- 
S2  -0.03259  -0.00567   0.02125              (--------*--------) 
S3  -0.04925  -0.02233   0.00459         (--------*--------) 
S4  -0.05492  -0.02800  -0.00108       (--------*--------) 
S5  -0.04925  -0.02233   0.00459         (--------*--------) 
S6  -0.03075  -0.00383   0.02309               (--------*--------) 
S7  -0.04759  -0.02067   0.00625         (--------*--------) 
S8  -0.05959  -0.03267  -0.00575     (--------*--------) 
                                     +---------+---------+---------+--------- 
                                  -0.060    -0.030     0.000     0.030 
 
 
S2 subtracted from: 
 
       Lower    Center     Upper     +---------+---------+---------+--------- 
S3  -0.04359  -0.01667   0.01025          (--------*--------) 
S4  -0.04925  -0.02233   0.00459         (--------*--------) 
S5  -0.04359  -0.01667   0.01025          (--------*--------) 
S6  -0.02509   0.00183   0.02875                 (--------*--------) 
S7  -0.04192  -0.01500   0.01192           (--------*--------) 
S8  -0.05392  -0.02700  -0.00008       (--------*--------) 
                                     +---------+---------+---------+--------- 






S3 subtracted from: 
 
       Lower    Center    Upper     +---------+---------+---------+--------- 
S4  -0.03259  -0.00567  0.02125              (--------*--------) 
S5  -0.02692  -0.00000  0.02692                (--------*--------) 
S6  -0.00842   0.01850  0.04542                      (--------*--------) 
S7  -0.02525   0.00167  0.02859                 (--------*--------) 
S8  -0.03725  -0.01033  0.01659             (--------*--------) 
                                    +---------+---------+---------+--------- 
                                 -0.060    -0.030     0.000     0.030 
 
 
S4 subtracted from: 
 
       Lower    Center    Upper     +---------+---------+---------+--------- 
S5  -0.02125   0.00567  0.03259                  (--------*--------) 
S6  -0.00275   0.02417  0.05109                        (--------*--------) 
S7  -0.01959   0.00733  0.03425                  (--------*--------) 
S8  -0.03159  -0.00467  0.02225              (--------*--------) 
                                    +---------+---------+---------+--------- 
                                 -0.060    -0.030     0.000     0.030 
 
 
S5 subtracted from: 
 
       Lower    Center    Upper     +---------+---------+---------+--------- 
S6  -0.00842   0.01850  0.04542                      (--------*--------) 
S7  -0.02525   0.00167  0.02859                 (--------*--------) 
S8  -0.03725  -0.01033  0.01659             (--------*--------) 
                                    +---------+---------+---------+--------- 
                                 -0.060    -0.030     0.000     0.030 
 
 
S6 subtracted from: 
 
       Lower    Center     Upper     +---------+---------+---------+--------- 
S7  -0.04375  -0.01683   0.01009          (--------*--------) 
S8  -0.05575  -0.02883  -0.00191      (--------*--------) 
                                     +---------+---------+---------+--------- 
                                  -0.060    -0.030     0.000     0.030 
 
 
S7 subtracted from: 
 
       Lower    Center    Upper     +---------+---------+---------+--------- 
S8  -0.03892  -0.01200  0.01492            (--------*--------) 
                                    +---------+---------+---------+--------- 















One-way ANOVA: modulus  
 
Source  DF     SS    MS     F      P 
Factor   7  13749  1964  4.69  0.001 
Error   40  16753   419 
Total   47  30502 
 
S = 20.47   R-Sq = 45.08%   R-Sq(adj) = 35.47% 
 
 
                        Individual 95% CIs For Mean Based on 
                        Pooled StDev 
Level  N   Mean  StDev  -------+---------+---------+---------+-- 
S1     6  31.73  13.89     (------*-----) 
S2     6  62.95  31.61                 (------*------) 
S3     6  47.30  13.03           (------*------) 
S4     6  57.30  20.36               (------*------) 
S5     6  39.31  12.39        (------*-----) 
S6     6  24.10   8.31  (------*-----) 
S7     6  39.47  10.17        (------*------) 
S8     6  79.58  35.32                        (------*------) 
                        -------+---------+---------+---------+-- 
                              25        50        75       100 
 
Pooled StDev = 20.47 
 
 
Tukey 95% Simultaneous Confidence Intervals 
All Pairwise Comparisons 
 
Individual confidence level = 99.73% 
 
 
S1 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S2   -6.55   31.21  68.98                    (------*-------) 
S3  -22.19   15.57  53.34                 (------*-------) 
S4  -12.19   25.57  63.34                   (------*-------) 
S5  -30.18    7.58  45.35               (-------*------) 
S6  -45.40   -7.64  30.13            (------*-------) 
S7  -30.03    7.74  45.50               (-------*------) 
S8   10.09   47.85  85.61                       (-------*------) 
                           ---------+---------+---------+---------+ 
                                  -50         0        50       100 
 
 
S2 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S3  -53.41  -15.64  22.12          (-------*------) 
S4  -43.41   -5.64  32.12            (-------*------) 
S5  -61.40  -23.63  14.13         (------*-------) 
S6  -76.61  -38.85  -1.09      (------*-------) 
S7  -61.24  -23.48  14.29         (------*-------) 
S8  -21.13   16.64  54.40                 (------*-------) 
                           ---------+---------+---------+---------+ 






S3 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S4  -27.76   10.00  47.76               (-------*-------) 
S5  -45.76   -7.99  29.77            (------*-------) 
S6  -60.97  -23.21  14.56         (------*-------) 
S7  -45.60   -7.83  29.93            (------*-------) 
S8   -5.49   32.28  70.04                    (------*-------) 
                           ---------+---------+---------+---------+ 
                                  -50         0        50       100 
 
 
S4 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S5  -55.75  -17.99  19.77          (------*-------) 
S6  -70.97  -33.21   4.56       (------*-------) 
S7  -55.60  -17.83  19.93          (------*-------) 
S8  -15.48   22.28  60.04                  (------*-------) 
                           ---------+---------+---------+---------+ 
                                  -50         0        50       100 
 
 
S5 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S6  -52.98  -15.22  22.55          (-------*-------) 
S7  -37.61    0.16  37.92             (-------*-------) 
S8    2.51   40.27  78.03                      (------*-------) 
                           ---------+---------+---------+---------+ 
                                  -50         0        50       100 
 
 
S6 subtracted from: 
 
     Lower  Center  Upper  ---------+---------+---------+---------+ 
S7  -22.39   15.37  53.14                 (------*-------) 
S8   17.72   55.49  93.25                         (------*-------) 
                           ---------+---------+---------+---------+ 
                                  -50         0        50       100 
 
 
S7 subtracted from: 
 
    Lower  Center  Upper  ---------+---------+---------+---------+ 
S8   2.35   40.11  77.88                     (-------*-------) 
                          ---------+---------+---------+---------+ 
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